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II. Introduction 
1. Background and aim of the work 
 
Fundamentally inflammation is a protective response to injury. The ultimate goal of this 
process is to rid the organism of both the initial cause of cell injury (e.g. microbes, 
toxins) and the consequences of such injury (e.g. necrotic cells and tissue). Further on it 
sets up, as far as possible, the stage for healing and reconstitution of the injured tissue. 
Without inflammation, infections would go unchecked, wounds would never heal, and 
injured organs might remain permanent festering sores. However, chronic inflammatory 
diseases (e.g. atherosclerosis, arthritis, colitis, multiple sclerosis or lung fibrosis) are the 
number one cause for morbidity and mortality in humans.  
 
An important process during the onset of the inflammatory response is the activation of 
the nuclear factor kappa B (NF-κB). NF-κB is an ubiquitous transcription factor, which 
is among others involved in the transcription of cytokines, chemokines, other 
transcription factors, adhesion molecules and growth factors. Adhesion molecules like 
E-selectin and intercellular adhesion molecule-1 (ICAM-1) are important for leukocyte 
recruitment and transmigration across the endothelium to the interstitial tissue. 
 
Garlic (Allium sativum L.) is one of the eldest medical plants known and was used as a 
treatment for heart disorders, tumors, worms, bites and other illnesses (Rahman, 2001). 
Since the 1960´s garlic attracted increasing attention by investigators around the world. 
It is proposed, that garlic extracts mediate anti-atherosclerotic properties by lowered 
cholesterol synthesis, LDL oxidation and fibrinolytic activity (Gebhardt, 1993; Lau, 
2001; Legnani et al., 1993). Further studies revealed anti-inflammatory properties of 
garlic (Geng et al., 1997). However, the described in vitro effects could not be 
conclusively reproduced in in vivo studies (Steiner et al., 1996a; Yeh and Liu, 2001; 
Silagy and Neil, 1994). So far the anti-atherosclerotic and anti-inflammatory effects and 
the underlying molecular mechanisms of garlic remain elusive. 
 
Edelweiss (Leontopodium alpinum Cass.) was used by inhabitants of the Alps as 
traditional folk medicine against inflammatory diseases of the gastrointestinal tract, 
diarrhea in human and animals (Pickl-Kerk, 1995; Kiene, 1992). However, up to now 
pharmacological studies of the anti-inflammatory properties of edelweiss constituents 
are missing completely. 
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Aim of the present work was the investigation of molecular mechanisms involved in the 
proposed anti-inflammatory properties of  A. sativum  and L. alpinum. In the course of 
the present thesis work, the following questions should be answered: 
 
1. Are compounds and extracts of A. sativum capable to inhibit NF-κB activation 
and subsequently the expression of adhesion molecules? 
 
2. Is garlic able to modify cytokine release from human blood cells? 
 
3. Is sulfur-fertilization of garlic plants a reasonable approach in order to improve 
the biological effects of garlic? 
 
4. Are constituents of  L. alpinum able to inhibit NF-κB activation and the 
succeeding expression of adhesion molecules and what pathways are involved? 
 
 
The present studies about garlic were part of the EU Garlic & Health project supported 
by the European Community. 
(QLK1-CT-1999-00498; www.plant.wag-ur.nl/projects/garlicandhealth). 
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2. Pathologic basis of inflammation 
 
Inflammation is the reaction of vascularized living tissue to local injury. The course of 
inflammation can be divided in acute and chronic conditions. Acute inflammation can 
last up to a few days and shows typical events like exudation of fluid and plasma 
proteins and the emigration of leukocytes. Chronic inflammation is of longer duration 
and is associated histologically with the presence of lymphocytes and macrophages at 
the site of inflammation, destruction of tissue by proteolytic enzymes and deranged 
healing by replacing damaged tissue against connective tissue (Cotran et al., 1999).  
 
2.1 Short overview of processes during acute inflammation  
 
After injury of tissue by microbial infections, chemicals and physical agents, increased 
blood flow in the injured area can be detected. In combination with an increased 
vascular permeability protein-rich extravascular fluid leaves the venous vessel through 
widened inter-endothelial cell junctions. Attracted by chemokines, like  monocyte 
chemoattractant protein-1 (MCP-1), leukocytes adhere to the endothelium by binding to 
adhesion molecules and transmigrate across the endothelium to the site of inflammation. 
Recruited leukocytes eliminate the harmful substance and set the stage for repair and 
healing (Cotran et al., 1999).  
 
2.2 Atherosclerosis, an inflammatory disease  
 
Atherosclerosis and its clinical manifestations of heart attack, stroke and peripheral 
vascular insufficiency contribute to a higher mortality and serious morbidity in the 
western world than any other disease. Commonly, atherosclerosis is characterized by 
the formation of intimal fibrous plaques that often have a central necrotic core rich in 
lipids (Lusis, 2000). Risk factors for the development of atherosclerosis are 
hyperlipidemia, hypertension, diabetes and cigarette smoking but also gender, age and 
genetic predisposition. The development of an atherosclerotic plaque starts with an 
injury of the endothelial lining in large and medium sized arteries (Gimbrone, 1999). A 
major cause of injury to the endothelium are elevated levels of low-density lipoprotein 
(LDL). LDL particles are trapped in the artery by specific interactions with 
apolipoprotein B (ApoB) containing lipoproteins and are oxidized to oxLDL (Watson et 
al., 1997). Oxidation of LDL can be inhibited by high-density lipoprotein (HDL) (Lin et 
al., 2002). Oxidized LDL stimulates the endothelium to produce pro-inflammatory 
substances, like adhesion molecules, chemokines and growth factors (Yla-Herttuala et 
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al., 1991; Dwivedi et al., 2001). The recruitment of leukocytes (especially monocytes, 
but not neutrophils) is mediated by adhesion molecules (e.g. P- and E-selectin, ICAM-1 
and VCAM-1) (Dong et al., 1998; Poston et al., 1992) and chemotactic factors (e.g. 
MCP-1) (Gerszten et al., 1999) as depicted in figure 1A. Monocytes are differentiated to 
macrophages, which start to take up oxLDL via scavenger receptors (SR-A and CD36) 
and transform into foam cells (Suzuki et al., 1997).  
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Figure 1: Endothelial dysfunction and fatty streak formation in atherosclerosis 
A: The earliest changes in the endothelium include increased permeability for LDL, leading to 
recruitment and transmigration of leukocytes by up-regulation of adhesion molecules. 
B: During the fatty streak formation monocytes and macrophages take up oxLDL and transform into 
foam cells. Smooth muscle cells are stimulated by various growth factors, including platelet derived 
growth factor and transforming growth factor, to migrate in the fatty streak. T-cells become activated by 
a series of cytokines, such as TNF-α, IL-2 and GM-CSF.  
Pictures are adopted from the homepage of the University of Arizona Biology Learning Center 
(http://www.blc.arizona.edu/courses/181gh/Lectures_WJG.01/LDL_F.01/atherosclerosis.html) 
 
T-cells and macrophages are activated by interaction of CD40 and CD40 ligand 
(CD40L) (Hansson et al., 2002). Activated macrophages and T-cells secrete cytokines, 
(like TNF-α, IL-1, interferon-γ (INF-γ) and transforming growth factor β (TGF-β)), 
proteolytic enzymes (especially metalloproteinases) and growth factors (platelet derived 
growth factor or insulin-like growth factor I). The secretion of cytokine and growth 
factors results in migration and proliferation of smooth muscle cells (SMC) (figure 1B). 
Progressive proliferation of SMC and macrophages, and recruitment of leukocytes leads 
to the formation of more complex lesions (Lusis, 2000). In this type of lesion foam cells 
die, leaving behind a growing mass of cell debris and extra-cellular lipids, which form 
the necrotic core. The necrotic core is walled off the lumen by a fibrous cap consisting 
of smooth muscle cells (Jonasson et al., 1986). Continuous leukocyte recruitment causes 
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the expansion of the lesion (figure 2A). Due to constant secretion of collagenases or 
gelatinases by macrophages and T-cells, the structure of the atherosclerotic plaque 
becomes vulnerable (Galis et al., 1994). Once the structure of the plaque becomes too 
unstable it breaks open and leads to thrombosis which can result in occlusion of the 
artery, leading to acute coronary events like stroke and myocardial infarction (figure 
2B).  
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Figure 2: Formation of advanced lesion and unstable fibrous plaques in atherosclerosis 
A: Formation of advanced atherosclerotic lesion is characterized by formation of a fibrous cap consisting 
of smooth muscle cells and underlying necrotic core. The necrotic core consists of a mixture of lipids, cell 
debris and leukocytes. 
B: Rupture of the atherosclerotic plaque occurs mainly at the lesion edges, which are rich in foam cells, 
as a result of constant thinning of the fibrous cap. Proteolytic enzymes, like collagenases, gelatinases and 
cathepsin are responsible for the degradation of the fibrous cap.  
Pictures are adopted from the homepage of the University of Arizona Biology Learning Center 
(http://www.blc.arizona.edu/courses/181gh/Lectures_WJG.01/LDL_F.01/atherosclerosis.html) 
 
A central mediator of atherogenesis is the transcription factor nuclear factor-kappa B. It 
was shown by Brand et al. that activated NF-κB is present in SMC, macrophages and 
endothelial cells in atherosclerotic lesions. However, in healthy vessels little activity has 
been measured (Brand et al., 1996). Activated NF-κB is associated with the 
pathophysiology of the vessel wall, including cytokine and chemokine production, 
expression of adhesion molecules and genes that regulate cell proliferation and cell 
survival (Collins and Cybulsky, 2001). 
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2.3 Activation of the nuclear factor - kappa B 
 
The nuclear factor - kappa B (NF-κB) is a ubiquitous dimeric transcription factor, 
involved in the activation of a large number of genes in response to infections, 
inflammation, and other stressful situations. Since the discovery in 1986 (Sen and 
Baltimore, 1986) the nuclear factor kappa B has been intensively investigated and is 
now one of the best understood transcription factors. It is composed of members of the 
REL family of DNA binding proteins including REL A (p65), NF-κB1 (p50;p105), NF-
κB2 (p52; p100), c-REL and REL B (Ghosh et al., 1998). They all recognize with high 
affinity a specific decameric DNA sequence motif, i.e. 5´-GGGPuNNPyPyCC-3´ 
(Grimm and Baeuerle, 1993). The nuclear factor kappa B can be rapidly activated by a 
wide range of stimuli, e.g. pro-inflammatory cytokines like tumor-necrosis factor (TNF) 
or interleukin-1 (IL-1), pathogens like lipopolysaccharide (LPS), viruses and physical 
and chemical stress, including oxidized lipids, oxidative stress and shear stress (Ghosh 
et al., 1998; Michiels et al., 2002; Li and Karin, 1999; Weber et al., 1999; Imberti et al., 
2000; Robbesyn et al., 2003). Under normal conditions active NF-κB is sequestered in 
the cytoplasm by specific inhibitors called IκB proteins (e.g. IκB-α, IκB-β, IκB-ε). 
Recent studies showed that IκB-NF-κB complexes may also shuttle from the cytosol to 
the nucleus and back (Malek et al., 2001; Huang et al., 2000; Lee and Hannink, 2002). 
Most known stimuli, except UV-radiation and H2O2, lead to the phosphorylation of the 
IκB-kinase complex (IKK) (Karin and Ben Neriah, 2000). IKK mediates 
phosphorylation of IκB at specific amino-terminal serine residues. For example, IκBα is 
phosphorylated at Ser32 and Ser36 (Traenckner et al., 1995).The phosphorylated IκB is 
then poly-ubiquitinylated at Lys21 and Lys22, marking it for degradation by the 26S 
proteasome (Baldi et al., 1996). After degradation of IκB free NF-κB dimers translocate 
to the nucleus. Activity of NF-κB is not exclusively regulated by signal-induced IκB 
degradation, but also by direct modification of NF-κB proteins through phosphorylation 
and acetylation (Sizemore et al., 1999; Wang and Baldwin, 1998; Chen et al., 2001). It 
has been demonstrated that various kinases (protein kinase A, casein kinase II and 
IKK2) phosphorylate p65 at a specific serine residue leading to enhanced transcriptional 
activity (Sakurai et al., 1999; Sizemore et al., 2002; Zhong et al., 1997). 
Phosphorylation of p65 is required for further modification by acetylation (Li and 
Verma, 2002). Recent reports described that a p50-p50-HDAC1 complex represses NF-
κB transcription in unstimulated cells After stimulation of cells, phosphorylated p65 
contacts with the co-activator CREB binding protein (CBP) and becomes acetylated. 
The complex of acetylated p65-CBP displaces the p50-p50-HDAC1 complex from the 
NF-κB binding site (Ashburner et al., 2001; Zhong et al., 2002).. 
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Figure 3: Scheme of NF-κB activation pathways  
Nuclear factor-κB (NF-κB) is activated by a wide range of stimuli, including lipopolysaccharide (LPS), 
tumor necrosis factor (TNF) and oxidized lipids. Ligation of diverse stimuli to the various receptors 
launches a cascade leading to the phosphorylation of the IκB-kinase complex (IKK): The IKK is 
composed of IKK-1 and IKK-2 and the regulatory subunit NF-κB essential modulator (NEMO). Activated 
IKK phosphorylates IκB, which leads to its degradation by the 26S proteasome, and allows NF-κB 
dimers to translocate to the nucleus. After IκB degradation NF-κB is subject to further phosphorylation 
and acetylation in order to control its activity. Possible target genes of NF-κB are intercellular adhesion 
molecule-1 (ICAM-1), E-selectin or IκB. Newly synthesized IκB displaces NF-κB from its DNA binding 
sites and subsequently the NF-κB-IκB complex translocates to the cytoplasm. 
 
Depending on the cell type and circumstance of its activation NF-κB can regulate 
different genes. NF-κB-regulated genes are cytokines (e.g. TNF, IL-1, IL-2), 
chemokines (monocyte chemoattractant protein (MCP-1, IL-8), transcription factors 
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(e.g. p50, cRel), NF-κB inhibitor IκBα, growth factors (M-CSF; G-CSF, GM-CSF) and 
many others (Ledebur and Parks, 1995; Albrecht et al., 1995; Quentmeier et al., 2000; 
Auphan et al., 1995; Baeuerle and Henkel, 1994; Guha and Mackman, 2001). The 
duration of NF-κB activity is regulated by histone deacetylase 3 (HDAC3). HDAC3 
deacetylates p65 and thus enhances the binding activity to IκB (Chen et al., 2001). 
Newly synthesized IκB terminates NF-κB activity by displacing NF-κB from its DNA 
binding sites. The nuclear export signal (NES) on the IκB protein marks the IκB-NF-κB 
complex for export to the cytosol (Huang et al., 2000). A simplified scheme of NF-κB 
activation pathways is depicted in figure 3. 
 
 
2.4 Leukocyte adherence and transmigration across the endothelium 
 
A critical function of inflammation is the proper delivery of leukocytes to the site of 
injury, in order to challenge intruding pathogens. However, unbalanced extravasation of 
leukocytes may prolong inflammation and induce tissue damage by releasing 
proteolytic enzymes (e.g. phosphatases, collagenases), chemical mediators (e.g. TNF, 
INF-γ) or toxic oxygen radicals. The coordinated interaction between the endothelium 
and leukocytes is divided into four sequential steps leading to leukocyte transmigration 
(figure 4). The hemoconcentration that follows vascular leakage in the early phase of 
the inflammatory response slows blood flow so that leukocytes can make contact with 
the endothelium. The initial contact is mainly mediated by the selectin family of 
adhesion molecules (e.g. P-selectin, L-selectin and E-selectin) and serves to attach and 
slow down the trespassing leukocyte, also referred to as rolling (Lorenzon et al., 1998). 
To stop rolling, the low affinity transient interactions of rolling must be replaced by 
high affinity adhesion between leukocyte and endothelium. Such strong adhesions  are 
triggered by stimuli (e.g. chemokines, cell surface proteins) presented by the 
endothelium (Baggiolini, 1998). After leukocyte activation integrins bind to their 
counterparts on the endothelium, namely adhesion molecules of the immunoglobuline 
family (e.g. ICAM-1, VCAM-1) (Reilly et al., 1995; Muller, 2002). Now the leukocyte 
stops rolling and begins to crawl on the endothelial cell surface. Although the preceding 
steps in leukocyte migration are potentially reversible, the transmigration of leukocytes 
(diapedesis) is the “point of no return”. The leukocyte undergoes a dramatic change in 
cell shape and extensive remodeling of cyto-skeleton, enabling it to squeeze through the 
endothelial junction (Hahn et al., 1997; Burns et al., 1997; Schenkel et al., 2002). 
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Figure 4: Recruitment of leukocytes to the site of inflammation 
At least four steps of the adhesion cascade are involved in leukocyte adhesion to and migration out of the 
vascular endothelium: (1) Attachment (tethering) and rolling, in which selectins and glyco-conjugated 
selectin-ligands are involved, (2) activation, mediated by soluble and/or membrane-bound chemokines, 
(3) firm adhesion and (4) transmigration, both mediated by integrins and their ligands, e.g. intercellular 
adhesion molecules etc.. Each of these four steps appears to be necessary for effective leukocyte 
recruitment, because blocking any step can severely reduce leukocyte accumulation in the tissue 
Adapted from the Weizmann Institute of Science  
(www. bioinfo.weizmann.ac.il/_ls/ ronen_alon/ronen_alon.html) 
 
 
 
Newer investigations showed, that adhesion molecules are not only docking-stations for 
leukocytes. Furthermore, ligation of ICAM-1 can induce VCAM-1 expression through 
activation of extra-cellular signal-regulated kinase (ERK) and AP-1. (Lawson et al., 
1999; Takahashi et al., 1996; Wang and Doerschuk, 2002). Adhesion molecules 
important for the recruitment of leukocytes are listed in table 1 (Aplin et al., 1998). 
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Endothelial molecule Leukocyte counter-ligand Major role 
P-selectin PSGL-1 Tethering, rolling 
Sialyl-Lewis X  L-selectin Tethering, rolling 
E-selectin ESL-1, CLA bearing sLeX, Tethering, rolling 
VCAM-1 VLA4  Tethering, rolling, firm adhesion 
ICAM-1 LFA-1, MAC-1 firm adhesion 
PECAM-1 PECAM-1 Diapedesis 
CD99 CD99 Diapedesis 
 
 
Table 1: Common leukocyte-endothelial cell adhesion molecules in inflammation 
PSGL-1, P-selectin glycoprotein 1; VLA-4, very late antigen 4; VCAM-1, vascular cell adhesion molecule 
1; LFA-1, leukocyte function antigen-1; ICAM-1, -2, intercellular adhesion molecule-1, -2; CR3, 
complement receptor 3; PECAM-1, platelet/endothelial cell adhesion molecule-1, ESL-1, E-selectin 
ligand, CLA, cutaneous lymphocyte antigen. 
(Adapted from Muller, 2002) 
 
 
2.5 Cytokines involved in inflammation 
 
Cytokines are proteins, mainly produced by activated lymphocytes and macrophages, 
but also by endothelial and epithelial cells or the connective tissue. They modulate the 
function of other cell types. Initially they were associated with cellular immune 
response. Nowadays it has been demonstrated that they also play a critical role in 
inflammation. Lipopolysaccharide (LPS) induces the liberation of cytokine (e.g. TNF-α, 
IL-1, IL-6, GM-CSF, IL-10) in monocytes and macrophages. Involved in this process 
are various mitogen activated protein kinases, like ERK, c-Jun N-terminal kinase (JNK) 
and p38 pathways and transcription factors, such as activator protein-1 (AP-1), serum 
response element (SRE) and cAMP-responsive enhancer-binding protein (CRE). Further 
the NF-κB and the PI3-kinase-AKT pathway plays an important role for the expression 
of cytokines in response to injuring stimuli (Guha and Mackman, 2001).  
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2.5.1 Tumor necrosis factor α (TNF-α) 
 
Human TNF-α is a non-glycosylated protein with a weight of 17 kDa and a length of 
157 amino acids. TNF-α is a pro-inflammatory cytokine and is mainly produced by 
activated monocytes and macrophages. Exposure of cells to TNF-α can either lead to 
apoptosis, activation of AP-1 and NF-κB or even to expression of anti-apoptotic genes 
(Baetu and Hiscott, 2002; Baud and Karin, 2001; Poulaki et al., 2002). TNF-α enhances 
activation of T-cells and induces proliferation of T-cells and B-cells. Tumor necrosis 
factor attracts macrophages and granulocytes to sites of inflammation. This attraction 
stimulates further macrophages and other immune cells to release tissue damaging, 
oxygen containing substances and prostaglandins to promote further inflammation. 
 
2.5.2 Interleukin 1 (IL-1) 
 
Interleukin-1 is the prototype of a “multifunctional” cytokine, since it affects nearly all 
cells. IL-1 gene family consists of three members IL-1α, IL-1β and IL-1 receptor 
antagonist (IL-1ra). The effects mediated by IL-1α and IL-1β are biologically more or 
less equivalent. 
IL-1 stimulates T-helper cells, B-cells, NK-cells and fibroblasts, promoting their 
proliferation and activation (Fauteux and Osmond, 1996; Collins and Oldham, 1995). 
IL-1 causes many alterations of endothelial functions in vivo. It promotes thrombotic 
processes and attenuates anti-coagulatory mechanisms (Joseph et al., 2002). IL-1 
therefore plays an important role in pathological processes such as venous thrombosis, 
arteriosclerosis, and vasculitis. Further IL-1 promotes the adhesion of neutrophils, 
monocytes, T-cells, and B-cells by enhancing the expression of adhesion molecules 
such as intercellular adhesion molecule-1 (ICAM-1) and E-selectin (McDouall et al., 
2001). IL-1 is also a strong chemoattractant for leukocytes; in vivo the injection of IL1- 
leads to the local accumulation of neutrophils at the site of injection. IL-1 also activates 
oxidative metabolism in neutrophils (Dinarello, 1996).  
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2.5.3 Interleukin 10 (IL-10) 
 
IL-10 is a homodimeric protein with subunits having a length of 160 amino acids, 
belonging to the group of anti-inflammatory cytokines. IL-10 inhibits the synthesis of a 
number of cytokines, such as interferon-γ (INF-γ), interleukin-1 and TNF-β in 
subpopulations of T-cells (Chung, 2001). In humans, IL-10 is mainly produced by T-
cells and monocytes, and it down-regulates the function of Th1 and Th2 T-cells, 
macrophages, monocytes. In macrophages stimulated by bacterial LPS, IL-10 inhibits 
the synthesis of IL-1, IL-6 and TNF-α mainly by promoting the degradation of cytokine 
mRNA (Lisinski and Furie, 2002; Denys et al., 2002). It also leads to an inhibition of 
antigen presentation. In human monocytes INF-γ and IL-10 antagonize each other's 
production and function (Moore et al., 2001). 
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3. Plants as anti-inflammatory drugs 
 
For thousands of years mankind treated maladies and ailments with plant extracts. The 
knowledge of the medical benefit of plants was not restricted to advanced cultures, like 
the Egyptians, as the glacier mummy in the Oetztal alps proofed (Spindler, 1995). 
Knowledge of the therapeutic use of plants and their extracts increased over centuries, 
leading to the discovery of drugs like acetylsalicylic acid, morphine or quinine. The 
quest nowadays is to set the assumed therapeutical effects of traditional medical plants 
on a scientific basis. Therefore it is important to elucidate the molecular mechanisms 
how plants mediate their therapeutic effects.  
 
3.1 Garlic (Allium sativum L.) 
 
Garlic is one of the most quoted herbs with medical potentials in literature. It was first 
mentioned in the ancient Codex Ebers 3500 years ago. Garlic was used all over the 
world by Chinese, Greeks, Egyptians, Indians, Koreans or Romans. Astonishingly garlic 
was used by the various cultures for treatment of similar symptoms. It was mainly given 
in order to cure ailments of the heart, gastrointestinal tract, infections and abnormal 
growth (Rivlin, 2001). These days it is assumed that garlic can mediate beneficial 
effects as an anti-thrombotic, anti-tumor and anti-atherogenic agent.  
 
3.1.1 Sulfur compounds and metabolites of garlic 
 
Dried garlic contains approximately 1 % sulfur. The main sulfur constituents of whole 
garlic are alliin, methiin, isoalliin and two γ-glutamylcysteins. When garlic tissue is 
harmed alliin, isoalliin and methiin undergo a rapid enzymatic transformation, forming 
mainly allicin. The enzymatic reaction is catalyzed by alliinase, a pyridoxal 5´-
phosphate dependent glycoprotein, normally stored in the vacuoles (Lawson, 1996; 
Kuettner et al., 2002; Lawson et al., 1991). The chemical reaction for the transformation 
is depicted in figure 5.  
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Figure 5: Transformation of S-alk(en)ylcysteine sulfoxides to thiosulfinates . 
Alliinase catalyzed transformation of isoalliin, alliin and methiin to allicin, trans-1-propenyl-2-propene 
thiosulfinates and allyl-methane-thiosulfinates. Typical amounts of compounds found in whole or crushed 
cloves are given in percent (w/w). Thiosulfinates are abbreviated as THS. (adopted from Lawson, 1996) 
 
Although garlic is one of the top supplements in the U.S. (Amagase et al., 2001), studies 
of the metabolic fate of garlic and the formation of metabolites are scarce. Analysis of 
garlic compounds in breath, plasma or gastric fluids revealed diallyl-disulfide (DADS), 
allyl-mercaptane (AM), methyl-allyl-sulfide (AMS) as possible metabolites in humans 
(Rosen et al., 2001; Egen-Schwind et al., 1992; Taucher et al., 1996). In another study 
allyl-methyl-sulfone (AMSO2) and allyl-methyl-sulfoxide (AMSO) were found in the 
stomach, plasma, liver tissue and urine of rats fed with DADS (figure 6). Peak levels of 
AMSO2 were found 24 – 48 h after administration of DADS (Germain et al., 2002).  
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Figure 6: Structures of selected garlic metabolites 
 
 
3.1.2 Therapeutic actions of garlic  
 
Around the world garlic has been intensively investigated during the last 100 years and 
has revealed its possible therapeutic effects against cancer, hyperlipidemia and 
atherosclerosis. 
 
Many in vitro and in vivo studies demonstrated the favorable effect of garlic on various 
forms of cancer. It is known that garlic reduces the carcinogenicity of nitrosamines, 
aflatoxin, dimethylbenz[a]anthracene or benzopyrene by affecting cytochrome P 
enzymes (Milner, 2001). Other groups showed that garlic is able to mediate apoptosis 
on several cancer cell lines (Antlsperger et al., 2003; Dirsch et al., 1998a; Dong et al., 
2001; Robert et al., 2001). Epidemiological studies revealed that garlic consumption can 
reduce the incidence of malignant diseases (Robert et al., 2001). 
 
Besides anti-tumoral properties, anti-atherogenic effects are associated with the usage of 
garlic. The anti-atherogenic effects can be divided in lipid-lowering, anti-oxidative and 
anti-inflammatory effects.  
In vitro studies demonstrated, that garlic constituents are able to reduce cholesterol 
biosynthesis by inhibiting hydroxymethylglutary-CoA reductase (HMG-CoA reductase) 
and squalene monooxygenase (Gebhardt, 1993; Liu and Yeh, 2002; Gupta and Porter, 
2001), whereupon higher concentrations of garlic are needed for squalene 
monooxygenase than for HMG-CoA reductase inhibition (Gebhardt, 1993). Further 
inhibitory effects on fatty acid and triglyceride synthesis by water-soluble organosulfur 
compounds of garlic have been reported recently (Liu and Yeh, 2001). Although garlic 
showed strong inhibitory effects on cholesterol synthesis in vitro, in vivo studies where 
controversial. Many studies observed that garlic reduces the levels of blood lipids 
(Steiner et al., 1996b; Yeh et al., 1997; Yeh and Yeh, 1994), however, other studies 
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demonstrated that blood lipid levels remain unaffected by garlic consumption 
(Isaacsohn et al., 1998). The differences of the observed effects may be due to the 
various garlic preparations used in each individual study. Furthermore the quality of the 
garlic used was not addressed in previous studies (Agarwal, 1996; Silagy and Neil, 
1994). 
Additionally, it has been shown that garlic attenuates oxidative stress by inhibiting 
hydrogen peroxide (H2O2) and superoxide anion (O2-) production via an augmented 
activity of the anti-oxidative enzymes superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPX) (Wei and Lau, 1998). Also it has been shown that garlic 
preparations are able to reduce copper-induced (Cu2+) oxidation of LDL (Imai et al., 
1994; Numagami and Ohnishi, 2001; Munday et al., 1999). Further it has been revealed 
that garlic interacts with nitric oxide (NO) production. It was demonstrated by Dirsch et. 
al. that allicin and ajoene are able to inhibit LPS-induced expression of inducible NO-
synthase (iNOS), similar results were shown recently for S-allyl cysteine (Dirsch et al., 
1998b; Kim et al., 2001). Lately published in vivo studies showed, that garlic 
preparations increase NO production in mice and rats (Pedraza-Chaverri et al., 1998; 
Morihara et al., 2002). However, recent in vitro studies demonstrated that the 
endothelial NO-synthase (eNOS) is not affected by garlic compounds (Kim et al., 2001; 
Leikert, 2002). This indicates that the observed increase of NO-production by garlic 
preparations is most likely not due to specific interactions with NO-synthetases. 
Furthermore, increasing evidence exists that garlic mediates immunomodulatory effects. 
It was shown that alliin and aged garlic extract increased phagocytosis activity of 
peripheral blood cells (PBC). Further, treatment of PBC with garlic extract modulated 
LPS-induced expression of cytokines (Kyo et al., 2001; Salman et al., 1999b; Hodge et 
al., 2002).  
It was demonstrated that aged garlic extracts are able to inhibit NF-κB activation after 
TNF-α and H2O2 treatment and subsequently the expression of adhesion molecules 
(Geng et al., 1997; Campbell et al., 2001; Ho et al., 2001). 
Another possible mechanism how garlic may suppress atherosclerosis consists in a 
reduced proliferation of smooth muscle cells and endothelial cells after treatment with 
garlic extracts (Efendy et al., 1997; Lee et al., 1994; Campbell et al., 2001). 
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3.2 Phytoestrogens 
 
Phytoestrogens are naturally occurring, plant-based diphenolic compounds that are 
similar in structure and function to estradiol. There are many types of phytoestrogens, 
but the major categories include isoflavones, lignans and coumestans. The estrogen-like 
activity of these compounds were identified in the 1940s, when an epidemy of infertility 
among sheep was investigated. The animals were grazing on clover (Trifolium sp) 
containing large amounts of formononetin, which is converted by bacteria in the rumina 
to daidzein and afterwards to equol. It has been demonstrated that the estrogenic effect 
was correlated with formononetin levels of various clover varieties, and not with 
genistein levels (Shutt, 1976). 
 
3.2.1 Isoflavones 
 
Isoflavones, the predominant type of phytoestrogens, are present in large amounts in 
soy beans and soy products. Peak levels of isoflavones (e.g. genistein and daidzein) can 
be detected 6 h after intake of soy products. Due to their phenolic nature they are 
rapidly transformed by mammalian UDP-glucuronosyltransferases and sulfotransferases 
and subsequently secreted (Hendrich, 2002). Epidemiologic studies have shown, that 
populations with high intake of soy products (south-east Asia) have a significant lower 
incidence of atherosclerosis than in countries with low soy consumption (Barnes, 1998). 
It is estimated that isoflavones mediate this effect mainly by reducing plasma 
cholesterol and LDL, as well as LDL oxidation (Kirk et al., 1998; Lovati et al., 1987; 
Clarkson, 2002; Samman et al., 1999). Pre-treatment with genistein inhibited NF-κB 
activation by blocking the degradation of IκB and the nuclear translocation of p65. As a 
result gene expression of adhesion molecules was reduced (Natarajan et al., 1998; 
Weber et al., 1995). These results were confirmed in an human ex vivo model, showing 
that soy isoflavone supplementation in healthy men prevented TNF-α induced NF-κB 
activation in blood lymphocytes (Davis et al., 2001).  
 
II Introduction 18 
 
OH
OH
O
OOH
OH
OH
O
O
OH
OMe
OOH
O
O
OH O
O
OH
OH
OH
OH
OH
OH
LignanCoumestanIsoflavones
Genistein Coumestrol Enterolactone
Enterodiol
β-Estradiol
Formononetin
 
 
Figure 7: Structures of β-estradiol and some selected phytoestrogens 
3.2.2 Lignans 
 
Lignans are chemically related to polymeric lignins of the plant cell wall and are found 
mainly in whole grain cereals, seeds, nuts and vegetables. Besides the group of plant 
lignans, two mammalian lignans (enterolactone and enterodiol; figure 7) were 
discovered as major compounds in serum, urine, bile and seminal fluids (Setchell et al., 
1981; Setchell et al., 1980). The mammalian-derived lignans differ from plant-derived 
(dietary) lignans in possessing phenolic hydroxyl groups only in the meta position of the 
aromatic rings. Two of the dietary precursors of these lignans are secoisolariciresinol 
(SECO) and matairesinol (MAT), which are present in garlic and sweet potatoes. A 
main source of plant lignans, however, is flaxseed, containing up to 25 mg/g of SECO-
diglucoside (figure 8) (Meagher et al., 1999).  
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Figure 8: Structures of lignan-type phytoestrogens 
 
The production of mammalian lignans depends on the presence of bacteria in the 
intestinal tract. Metabolism studies showed that peak levels of enterodiol (END) and 
enterolactone (ENL) are found 9 h after flaxseed consumption (Nesbitt et al., 1999).  
END and ENL received much attention during the last 20 years because of their 
estrogen-like biological properties. It was demonstrated that highest urine and plasma 
levels of ENL and END were found in countries with low cancer and coronary heart 
disease incidence. Lowest levels of mammalian lignans were found in breast cancer 
patients or women with high risk for breast cancer (reviewed by Adlercreutz and Mazur, 
1997). Although a critical review of 18 studies addressing the influence of 
phytoestrogens on breast cancer development found that there is no evidence for 
reduced cancer risk by consumption of phytoestrogens (Peeters et al., 2003). 
In recent years many biological activities of different lignans were revealed by scientists 
around the world. It was demonstrated that lignans are able to inhibit proliferation of T-
cells and various cancer cell lines (Cho et al., 2001a; Bohnenstengel et al., 1999; Filleur 
et al., 2001; Cho et al., 2001b). Furthermore it was shown that NF-κB could be 
effectively inhibited by plant lignans (Baumann et al., 2002; Cho et al., 2002), as well 
as expression of adhesion molecules and the liberation of pro-inflammatory cytokines 
(Ahn et al., 2001; Yesilada et al., 2001; Cho et al., 2001b). 
Additionally, it has been published that some plant lignans are able to interfere with the 
replication of the human immunodeficiency virus type 1 (HIV-1) (Gnabre et al., 1995; 
Eich et al., 1996). 
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3.3 Edelweiss (Leontopodium alpinum Cass.) 
 
Edelweiss is a small, ornamental and protected flower that can be found in the 
mountains of Europe and Asia. In the Alps, edelweiss plays an important role in the 
traditional life of people. Taking into account how well known this plant is it is very 
astonishing that so far only very few phytochemical investigations have been 
performed. Up to now flavonoids, phenolic acids, terpens, a chromane derivate and 
some bisabolane derivates have been isolated from edelweiss (Stuppner H. et al., 2002; 
Comey N. et al., 1997; Grey A.I. et al., 1999). 
It is reported that Leontopodium alpinum was used in traditional medicine for treatment 
against cancer (Hartwell, 1968). Further it was used to cure maladies of the gastro-
intestinal tract, like abdominal cramping or pain, diarrhea, poisoning, toxemia as well as 
bronchitis (Knechtl, 1992; Pickl-Kerk, 1995; Kiene, 1992). However, pharmacological 
studies are missing completely. 
For our investigations of the anti-inflammatory effects of Leontopodium alpinum Prof. 
Dr. H. Stuppner (University of Innsbruck) provided us several constituents isolated 
from the roots of edelweiss, namely two bisabolane sesquiterpenoids called bisabolane 
A and bisabolane CD and one plant-lignan called MAB F7 (figure 9). 
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Figure 9: Structures of provided constituents of Leontopodium alpinum Cass. 
III. Materials and Methods 
 
1. Materials 
 
Agarose was purchased from BMA. 10 % non-fat dry milk (Blotto) and Bradford 
reagent were from BioRad. HEPES, TRIS, TRIS⋅HCl and Triton X-100 were purchased 
from Roth. Folin & Ciocalteu's phenol reagent, bovine serum albumin, Na2EDTA and 
Na2EGTA were from SIGMA. Collagenase A was purchased from Roche. Restriction 
enzymes (BamHI, HindIII, AatII and SspI) were purchased from MBI Fermentas. 
Medium 199, RPMI 1640, penicillin/streptomycin and tumor necrosis factor-α were 
from PAN-Biotech. Endothelial cell growth medium was from Promocell. Phenolred-
free DMEM was purchased from Bio Whittaker. Foetal calf serum and Collagen G was 
from Biochrom. Tryptone, yeast extract, Lennox Broth base and Lennox Broth agar 
were purchased from GibcoBRL. All other chemicals were from Roth if not stated 
otherwise. 
 
2. Plant materials and single constituents 
 
2.1 Garlic (Allium sativum L.) 
 
2.1.1 Garlic constituents 
 
The garlic constituents diallyl-disulfide (DADS), allyl-mercaptane (AM), allicin 
(DADSO), allyl-methyl-sulfoxide (AMSO) and allyl-methyl-sulfide (AMS) were 
obtained from Prof. Dr. J. Auger (Université de F. Rabelais, Tours, France).  
γ-glutamylcystein (γ-GC) was obtained from Dr. T. Haffner (Lichtwer Phama, Berlin, 
Germany). S-allylcysteine (SAC) was obtained from Wakanuga (Wakanuga of America 
Co., Madero, USA). Purity of DADS, AM, AMS, γ-GC and SAC was >95 %, purity of 
allicin was ~ 80% judged by HPLC. 
The garlic constituents were solved either in medium or DMSO at the concentrations 
needed and stored at –87°C until use. 
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2.1.2 Garlic powders 
 
French garlic powders from Allium sativum Morado, Allium sativum Morasol and 
Allium sativum Printanor in different fertilization stages were obtained from Dr. R. 
Kahane (COOP D´OR, Dijon, France) 
Spanish garlic powders from Allium sativum Morado, Allium sativum Morasol and 
Allium sativum Printanor in different fertilization stages were obtained from Prof. J. 
Martin Sanchez (Universidad de Cordoba, Cordoba, Spain) 
 
Variety Fertilization  
(SO42- U/ha) 
Origin Year of harvest 
Morasol 0 France 2000 
Morasol 50 France 2000 
Morasol 100 France 2000 
Morasol 200 France 2000 
Morasol 0 Spain 2000 
Morasol 50 Spain 2000 
Morasol 100 Spain 2000 
Morasol 200 Spain 2000 
Morado 0 France 2000 
Morado 50 France 2000 
Morado 100 France 2000 
Morado 200 France 2000 
Morado 0 Spain 2000 
Morado 50 Spain 2000 
Morado 100 Spain 2000 
Morado 200 Spain 2000 
Printanor 0 France 2001 
Printanor 50 France 2001 
Printanor 100 France 2001 
Printanor 200 France 2001 
Printanor 0 Spain 2001 
Printanor 50 Spain 2001 
Printanor 100 Spain 2001 
Printanor 200 Spain 2001 
Printanor 0 France 2001 
Printanor 100 France 2001 
Printanor 200 France 2001 
Printanor 400 France 2001 
Printanor 0 Spain 2001 
Printanor 100 Spain 2001 
Printanor 200 Spain 2001 
Printanor 400 Spain 2001 
Printanor 2000 Spain 2001 
 
Table 2: Used garlic powders 
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All garlic powders used for our experiments are listed in table 2. Cultivation, processing 
and analysis of garlic powders are described in detail by Arnault et al. (Arnault I. et al., 
2003). For extraction garlic powders were suspended in either RPMI 1640 or DMSO 
and shaken vigorously for 30 minutes. Thereafter the unsolvable parts were separated 
by centrifugation (24,000xg; 5 min) and the supernatant was sterilized by filtration. The 
filtrate was either used directly or was diluted with medium or DMSO to the 
concentration needed. Garlic extracts were prepared fresh for each experiment. 
 
2.2 Constituents from Leontopodium alpinum Cass. (Edelweiss) 
 
The constituents bisabolane A, bisabolane CD and MAB F7 from L. alpinum were 
obtained from Prof. Dr. H. Stuppner (University of Innsbruck, Innsbruck, Austria). 
Purity of substances was >95 % judged by HPLC. 
The edelweiss constituents were solved in DMSO at the concentrations needed and 
stored at –20°C until use. 
 
3. Cell culture 
 
Solutions: 
  
PBS:      PBS+ :  
Na2HPO4 8.0 mM   NaCl           137 mM 
KH2PO4   1.5 mM    KCl            2.6 mM 
NaCl            160 mM     Na2HPO4 x 2 H2O       8.1 mM  
H2O                KH2PO4         1.5 mM 
      MgCl2 x 6 H2O      0.5 mM 
      CaCl2 x 2 H2O      0.9 mM 
      H2O                 
 
Trypsin/EDTA (T/E):   PBS + Collagen: 
Trypsin (0,05%)     0.5 g   Collagen G (Biochrom) 1.25 ml 
EDTA   (0,02%)  0.2 g   PBS           ad 500 ml 
PBS       ad 1000 ml  
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3.1 Human umbilical vein endothelial cells 
 
Human endothelial cells were isolated from umbilical veins (HUVECs). The vein was 
washed with 50 ml PBS+ then filled with 0.1 g/l collagenase A (Roche) in PBS+ and 
incubated at 37°C for 40 min. Subsequently the vein was washed with 50 ml M 199 
(PAN Biotech) containing 10% FCS (Biochrom). The eluate was centrifuged at ~220xg, 
20°C for 10 min and the pellet was resuspended in 5 ml ECGM (Promocell) and grown 
in 25 cm2 tissue culture flasks (TPP AG) pre-coated with 0.25 % Collagen G 
(Biochrom) at 37°C and 5% CO2. When cells reached confluence they were washed 
with PBS and subsequently detached with trypsin/EDTA. The digestion was stopped by 
addition of M 199 + 10 % FCS. After centrifugation at ~220xg cells were resuspended 
in ECGM (Promocell) and plated in pre-coated 75 cm2 tissue culture flask (TPP AG). 
HUVECs were sub-cultured 1:3 in culture flasks or plates and grown until confluence. 
Experiments were performed with cells of passage number  three grown in 6-, 12-, or 
24-well plates (TPP AG). HUVECs were found > 95% pure as judged by FACS 
analysis, using an antiserum against the “von Willebrand”-protein (Serotec). 
 
3.2 Human embryonic kidney cell line 293 
 
Cells of the human embryonic kidney cell line 293 (HEK 293) were grown in phenol 
red-free DMEM (Biowitthaker) supplemented with 10 % FCS (Biochrom), 2 mM 
glutamine and penicillin/streptomycin (PAN Biotech) at 37°C and 5 % CO2 in 75 cm2 
tissue culture flasks. Cells were split when reaching ~85-90 % confluency. Cells were 
washed with phosphate buffered saline (PBS) and subsequently detached with 
trypsin/EDTA in PBS and spilt 1:10. 
 
3.3 Human leukemic T-cell line  
 
Human akute leukemic T-cell line (Jurkat) was grown in RPMI 1640 (PAN Biotech) 
supplemented with 10 % FCS ( PAA Laboratories) and 1 mM pyruvate (Sigma) at 37°C 
and 5 % CO2 in 75 cm2 tissue culture flasks. Cells were split when reaching a 
concentration of ~ 1x106 cell/ml. 
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4. Flow cytometric analysis of cell adhesion molecules  
  
FACS-buffer:    
NaCl     8.12 g  
KH2PO4  0.26 g  
Na2HPO4 2.35 g  
KCl    0.28 g  
Na2EDTA   0.36 g  
LiCl     0.43 g  
Na-azide   0.20 g  
H2O           ad 1000 ml pH 7.37  
  
 
Antibodies for flow cytometry:  
 
immunogen conjugate isotype vendor 
human-CD106 (VCAM-1) FITC mouse IgG1 Biosource 
human-CD54   (ICAM-1) FITC mouse IgG1 Biosource 
human-CD62E (E-selectin) FITC mouse IgG1 Calbiochem 
isotype control FITC mouse IgG1,κ PharMingen 
human-“von-Willebrand”-factor FITC sheep IgG Serotec 
 
Table 3: Antibodies used for flow-cytometry 
 
Experimental procedure:  
  
Analysis of cell adhesion molecules was carried out as described before (Weber et al., 
1999). HUVECs were  grown in 12 well-plates until confluence and were left either 
untreated or were treated with 5 ng/ml TNF-α (PAN Biotech). The effect of the 
following substances on the surface expression of cell adhesion molecules was 
determined: diallyl disulfide, allyl mercaptane, MAB F7. Substances were added to the 
cells 2 h before TNF-α. After 4 h (E-selectin) or 16 h (ICAM-1, VCAM-1), surface 
expression of adhesion molecules was measured by flow cytometry using FITC-labeled 
antibodies against ICAM-1, VCAM-1, and E-selectin. Briefly, cells were washed with 
PBS three times and trypsinized. The digestion was stopped by addition of M 199 
containing 10% FCS. After scraping the cells with a rubber policeman and transferring 
them into FACS tubes, cells were centrifuged at 220xg (20°C, 10 min). The cell pellet 
was washed with PBS three times. Cells were incubated with 1 % bovine serum 
albumin (BSA) for 30 min at room temperature. Subsequently the adequate antibody 
was added and incubated for 2 h at room temperature in the dark. After incubation cells 
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were re-suspended in a volume of 300 µl PBS for flow cytometric analysis. For analysis 
10,000 cells/sample were counted and evaluated. Specific binding of antibodies was 
controlled with a FITC-labeled mouse IgG1 isotype control (PharMingen). Surface 
expression of adhesion molecules was quantified by flow cytometry (Becton Dickinson) 
at λem 530 nm (green fluorescence, FL-1) after excitation at 488 nm with an argon laser.  
 
5. Electrophoretic mobility shift assay  
  
5.1 Isolation of nuclear and cytosolic proteins  
  
Solutions:  
  
Buffer A:      Buffer B:  
HEPES pH 7.9  10  mM         HEPES pH 7.9    20  mM    
KCl    10  mM   NaCl   0.4 M  
EDTA    0.1 mM      EDTA   1.0 mM  
EGTA    0.1 mM      EGTA    1.0 mM  
DTT    1.0 mM  DTT   1.0 mM 
PMSF    0.5 mM  PMSF   1.0 mM 
H2O       Glycerol (100%)    25  %  
       H2O 
 
Experimental procedure:  
 
HUVECs were cultured in 6-well plates until confluence and were either left untreated 
or stimulated with TNF-α (10 ng/ml) for 30 min to 1 h in the presence or absence of 
various substances as indicated. Nuclear and cytosolic extracts were prepared as 
described in (Schreiber et al. 1989). Briefly, HUVECs were washed with PBS, scraped, 
and resuspended in 400 µl of hypotonic buffer A. Cells were allowed to swell on ice for 
15 min. Nonidet P-40 (10%, 25 µl) was added followed by 10 sec of vigorous vortexing 
and centrifugation at 12,000 x g for 30 sec. The supernatant (containing the cytosolic 
proteins) was removed. The nuclear pellet was extracted with 50 µl of hypertonic buffer 
B by shaking at 4°C for 15 min. The extract was centrifuged at 12,000xg and the 
supernatant was frozen at -85°C. Protein  concentrations were determined by the 
method of Lowry (Lowry et al., 1951) 
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5.2 Radioactive labeling of oligonucleotides   
  
Solutions:  
  
5 x binding buffer:          Loading buffer:      
Glycerol     20   % (v/v)  Tris-HCl pH 7,5      250 mM 
MgCl2        5.0 mM   Bromphenolblue      0.2 % (m/v) 
EDTA        2.5 mM   Glycerol             40 % (v/v) 
NaCl    250.0 mM  
Tris-HCl   pH 7,5     50.0 mM  
DTT        2.5 mM 
H2O 
 
10 x TBE buffer:          PAGE-non denaturing 4.5% gel:    
Tris-Base   900 mM  10 x TBE       1 ml 
Boric acid     25 mM   Acrylamide-bis 30 %      3 ml 
H2O        ad 1000 ml   Glycerol (100%)    0.5 µl 
TEMED      10 µl 
APS 10% (m/v)   150 µl 
H2O               15.5 ml 
 
Experimental procedure:  
  
A 22-mer double-stranded oligonucleotide probe containing a consensus binding-
sequence for NF-κB (5'-AGT TGA GGG GAC TTT CCC AGG C-3', Promega), AP-1 
(5`-CGC  TTG  ATG  AGT  CAG  CCG  GAA-3`, Promega) or AP-2 (5`-GAT CGA 
ACT GAC CGC CCG CGG CCC GT-3`, Promega) was 5' end-labeled with 10 µCi 
[32P]-ATP (Amersham) using T4 polynucleotide kinase (USB). 
  
5.3 Binding reaction and electrophoretic separation  
 
Equal amounts (i.e.10 µg) of nuclear protein were incubated (20 min, RT) in a 15 µl 
reaction volume containing 10 mM Tris-HCl pH 7.5, 5 x 106 cpm radiolabeled 
oligonucleotide probe, 2 µg polydeoxyinosinic-deoxycytidylic-acid (ICN), 4% glycerol, 
1 mM MgCl2, 0.5 mM EDTA,  50 mM NaCl, and 0.5 mM DTT. Nucleoprotein-
oligonucleotide complexes were resolved by gel-electrophoresis (4.5% non-denaturing 
polyacrylamide gel, 100 V) and bands were visualized by phosphoimaging (Packard). 
Specificity of the DNA-protein complex was confirmed by competition with a 100-fold 
excess of unlabeled NF-κB, AP-1, and AP-2 oligo nucleotides, respectively. 
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6. Determination of cell viability by propidium-iodide 
staining 
 
The viability of cells was determined by propidium-iodide (PI) staining. Cells were 
grown in 24-well plates and treated with various substances for up to 24 hours. Then 
cells were trypsinized, washed with PBS and incubated with 8 ng/well PI for 30 min at 
room temperature in the dark. PI positive (= dead cells) were quantified by flow 
cytometry (Becton Dickinson) at λem 585 nm (red fluorescence, FL-2) after excitation at 
488 nm with an argon laser. 
 
7. Dual luciferase assay  
 
For the dual luciferase reporter gene assay (DLR) the following plasmids were used:  
 
name promoter reporter gene vendor 
pNF-κBluc NF-κB (5x) firefly - luciferase Stratagene 
pFC-Mekk Positive control for pNF-κBluc Stratagene 
pEGFP-N1 CMV green fluorescent protein Clontech 
pRL-TK HSV-TK renilla luciferase Promega 
 
Table 4: List of used plasmids 
 
Solutions: 
 
SOB-Media:      SOB-Agar: 
Tryptone      20 g   Agarose  15 g 
Yeast extract        5 g   SOB – Media     ad 1000 ml 
NaCl      0.5 g 
KCl      2.5 mM  SOC-Media: 
MgCl2       20 mM  Glucose   20 mM 
H2O         ad 1000 ml  SOB – Media     ad 1000 ml 
Adjust pH to 7.0 
 
Lennox Broth-Media:   Lennox Broth -Agar: 
LB Broth Base       20 g  LB-agar      32 g 
Glucose          1 g  Glucose         1 g 
H2O          ad 1000 ml H20         ad 1000 ml 
Adjust pH to 7.2 
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TFB I:     TFB II: 
MOPS   10 mM  RbCl2   100 mM 
RbCl2   10 mM  MnCl2     50 mM 
CaCl2   75 mM  K+-acetate    30 mM 
Glycerol  15 % (v/v)  CaCl2     10 mM 
H20      Glycerol    15 % (v/v) 
Adjust pH to 7.0    H2O 
      Adjust pH to 5.8 
 
Alkaline lysis buffer I (ALP I)  Alkaline lysis buffer II (ALP II) 
Glucose   50 mM NaOH   0.2 N 
Tris-HCL  pH 8.0 25 mM SDS   1 % (w/v) 
EDTA    10 mM H2O 
H20 
 
Alkaline lysis buffer III (ALP III)  Tris/EDTA (TE) 
K+-acetate (5M)  60    ml Tris-HCl pH7.5 10 mM 
Glacial acetic acid  11.5 ml  Na-EDTA    1 mM 
H2O    28.5 ml  RNAse  50 µg/ml 
      H2O 
 
7.1 Preparation of competent E.coli DH5α 
 
Bacteria (E.coli strain DH5α) from a frozen stock were plated on SOB agar plate and 
grown at 37°C for 16 h. Several single colonies were suspended in 30 ml of SOB 
medium. Bacteria were grown at 37°C (200 rpm). When reaching  an OD600 of ~ 0.4 
bacteria were sedimented at 2,700xg (10 min at 4°C). The pellet was resuspended in 30 
ml ice-cold TFB I buffer and incubated for 30 min on ice. Afterwards bacteria were 
pelleted at 2,700xg (10 min at 4°C) and then resuspended in 4 ml ice-cold TFB II 
buffer. 140 µl DMSO were added and incubated for 15 min on ice. Afterwards again 
140 µl DMSO were added and then aliquots of competent E.coli were shock-frozen in 
liquid nitrogen and stored at –87°C. 
 
7.2 Transformation of DH5α 
 
50 µl of competent DH5α bacteria were incubated for 30 minutes with 1 ng plasmid 
DNA on ice. Then the bacteria were heat-shocked for 90 seconds at 42°C and 
afterwards put on ice for 2 minutes. 800 µl SOC-Media were added and the bacteria 
were incubated at 37°C (200 rpm for 45 minutes). After incubation, up to 200 µl of the 
bacteria suspension were plated on selective (ampicillin 50 µg/ml or kanamycin 30 
µg/ml) SOB-agar and incubated overnight at 37°C. 
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7.3 Mini preparation of plasmids 
 
Single colonies of transformed DH5α were picked and each colony incubated in 2 ml 
selective LB-Media at 37°C (300 rpm for 16-20 h). 1.5 ml of cultured bacteria were 
centrifuged at 24,000xg, 4°C for 30 seconds and the pellet was resuspended in ALP I. 
Thereafter ALP II was added and the mixture was heavily shaken. Subsequently ice 
cold ALP III was added. The lysate was incubated on ice and then centrifuged at 
24,000xg for 5 minutes at 4°C. 400 µl from the supernatant were separated and the 
DNA was precipitated from the supernatant with 800 µl of ice-cold ethanol 100%. DNA 
was isolated by centrifugation at 24,000xg at 4°C for 5 minutes and subsequently 
washed twice with 70% ethanol. The air dried pellet was dissolved in TE. Plasmids 
were cut with appropriate restriction enzyme and then identified by size with agarose 
gel electrophoresis after ethidium bromide staining. 
7.4 Maxi preparation of plasmids 
 
After successful mini preparation 0.5 ml of the transformed bacteria were incubated in 
100 ml selective LB-Media and incubated overnight at 37°C and 300 rpm in a water 
bath. The suspension was centrifuged at 6,000xg for 15 minutes at 4°C. The isolation 
was carried out with EndoFreeTM Plasmid Maxi-Kit (Qiagen) according to the 
manufacturer’s description. 
 
7.5 Transfection of HEK 293 cells 
 
1x106 HEK 293 cells were seeded in a 60 mm dish the night before transfection and 
grown at 37°C, 5% CO2. On the following day 1 µg pNF-κBluc, 100 ng pRL-TK and 
1.1 µg salmon sperm DNA were mixed and 250 µl of sterile 250 mM CaCl2 and 250 µl 
sterile 2xHBS pH 7.06 (280 mM NaCl; 10 mM KCl; 1.5 mM Na2HPO4*2H2O; 12 mM 
Glucose; 50 mM HEPES) were added, mixed carefully and incubated for 45 minutes at 
room temperature. The precipitate was added to the cells and then incubated for 8 hours 
at 37°C, 5 % CO2. Afterwards the medium was aspirated and the cells were washed 
twice with PBS+ and then fed with fresh medium. On the next day, transfected cells 
were seeded in 96-well plates at a concentration of 1.5x104 cells/well and grown for 
additional 16 h. Transfection efficiency was judged by fluorescence microscopy 
evaluating GFP-transfected cells. 
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In order to rule out interactions between different plasmids control cells were 
transfected with pNF-κB, pRL-TK or salmon-sperm alone. Cells co-transfected with 
pNF-κB, pRL-TK, pFC-MEKK and salmon-sperm were used as positive control. 
 
7.6 Dual luciferase reporter assay 
 
Cells were pre-incubated for 2 h with various substances and subsequently stimulated 
with 1 ng/ml TNFα for 6 h. Then cells were washed twice with PBS+ and afterwards 
lysed. NF-κB activity was measured by the Dual Luciferase Reporter Assay (Promega) 
according to manufacturer’s description with a AutoLumat plus (Berthold). 
 
8. Cytokine liberation assay 
 
Solutions 
 
Wash solution   Blocking solution 
Tween 20  0.05 %  BSA    3 % 
PBS     PBS 
 
Coating Buffer:   Streptavidin-peroxidase: 
NaHCO3  0.1 M  Streptavidin-peroxidase 1 µg/ml 
H2O     BSA    3% 
Adjust pH to 8.2   PBS 
 
immunogen isotype usage vendor 
hIL-1β mouse IgG2bκ capture Endogen 
hIL-1β recombinant protein standard Endogen 
hIL-1β biotinylated mouse IgG1κ detection Endogen 
hIL-6 goat IgG capture R & D 
hIL-6 recombinant protein standard R & D 
hIL-6 biotinylated goat IgG detection R & D 
hIL-10 rat IgG1 capture PharMingen 
hIL-10 recombinant protein standard PharMingen 
hIL-10 biotinylated rat IgG2a detection PharMingen 
hTNF-α mouse IgG1κ capture Endogen 
hTNF-α recombinant protein standard Endogen 
hTNF-α biotinylated mouse IgG1κ detection Endogen 
hINF-γ  capture Endogen 
hINF-γ recombinant protein standard Endogen 
hINF-γ biotinylated  detection Endogen 
 
Table 5: Used antibodies for ELISA 
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8.1 Incubation of human whole blood with garlic powder extracts 
 
To study the LPS-induced cytokine release from human whole blood, 1,600 µl of RPMI 
1640 (Biochrom) supplemented with 100 IU/ml penicillin/streptomycin (Biochrom) was 
pipetted into a polypropylene reaction tube, and 10 ng/ml LPS from Salmonella abortus 
equi (Sigma) and either a garlic constituent or garlic powder extract was added. Finally, 
400 µl of heparinized whole blood (withdrawn in lithium-heparin-S-monovettes from 
Sarstedt) from healthy volunteers were added (final assay volume, 2 ml). The tubes 
were incubated at 37°C and 5% CO2 for 16-20 h. After incubation, the tubes were 
shaken, and blood cells were sedimented by centrifugation (16,000xg, 2 min). The cell-
free supernatants were stored at -80°C until cytokine measurement.  
 
8.2 Cytokine measurement 
 
Cytokines in the cell-free supernatants were quantified by sandwich ELISA. First 
ELISA plates (Greiner) were coated overnight at 4°C with 50 µl/well coat antibody in 
0.1 M NaHCO3, pH 8.2. After blocking with 200 µl/well PBS supplemented with 3% 
bovine serum albumin (Serva), pH 7.0, for 2 h at room temperature the plates were 
washed twice with PBS/0.05% Tween 20. Sample (50 µl/well) and tracer antibody 
(50 µl/well) in PBS/bovine serum albumin 3% were added and incubated for 2 h for all 
ELISA from Endogen. For measuring IL-6 and IL-10 100 µl of sample was incubated 
for 3 h, then the plate was washed four times, and then 100 µl of tracer antibody was 
incubated for 2 h. After six wash cycles, plates were incubated for 30 min with 
streptavidin-peroxidase (Dianova). After eight washes, 100 µl/well 3,3',5,5'-tetramethyl-
benzidine liquid substrate solution (Sigma) was added and incubated at room 
temperature for 5 to 30 min. After addition of 50 µl/well stop solution (1 M H2SO4), 
absorption was measured at 450 nm using a reference wavelength of 690 nm.  
 
9. Real-time RT-PCR 
 
9.1 RNA isolation and reverse transcription 
  
HUVECS were grown in 6 cm dishes to confluency. Cells were pre-incubated with 
MAB F7 or MG-132 at the indicated concentrations or with DMSO alone for 2 h. 
Afterwards 5 ng/ml TNF-α was added and cultured for additional 4 h. mRNA was 
isolated with RNeasy KIT (Qiagen) according to manufactures description. Total RNA 
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concentration was determined from spectrophotometric optical density measurement 
(260 and 280 nm). Reverse transcription was carried out using the RNA PCR Core Kit 
(PE Applied Biosystems). Each reaction tube contained 2 µg of total RNA in a volume 
of 100 µl containing 5.5 mM MgCl2, 1x RT Buffer, 500 µM of each dNTP, 2.5 µM of 
random hexamers, 0.4 U/µl RNAse inhibitor, 1.25 U/µl MultiScribe reverse 
transcriptase and water to volume. RT-reactions were carried out in a GeneAmp PCR 
system 9700 (Applied Biosystems) at 25°C for 10 min, 48°C for 30 min and 95°C for 5 
min. cDNA was stored at –20°C. 
 
9.2 Real-time PCR  
 
The cDNA sequence for ICAM-1 was obtained from NCBI. PCR primers and TaqMan 
fluorogenic probes were designed using the Primer Express 2.0 software program (PE 
Applied Biosystems). TaqMan TAMARA probes and primers were purchased from PE 
Applied Biosystems; forward primer: 5’-GCAGACAGTGACCATCTACAGCTT-3’;  
reverse primer: 5’-CTTCTGAGACCTCTGGCTTCGT-3’ ; TaqMan probe : 
5’-CCGGCGCCCAACGTGATTCT-3’. Real-time PCR was performed using the 
TaqMan Universal PCR Master Mix, 900 nM of forward primer, 300 nM of reverse 
primer, 200 nM of probe and 200 ng of ICAM-1 total RNA. All samples were run in 
duplicate. Standard curves were constructed on a 1:2 serial dilution of total RNA. As 
internal standard the TaqMan Pre-Developed Assay Reagents (Applied Biosystems) 
against 18s RNA was used. Amplification conditions included 50°C 2 min, 95°C 10 
min and run for 40 cycles at 95°C 15 sec and 60°C 1 min on the GeneAmp 5700 
(Applied Biosystems). The threshold cycle was determined by the software, based on 
the generated standard curves. 
 
10. Western blot analysis 
 
Solutions: 
 
Lysis buffer       SDS Sample buffer (5x)  
Tris-HCl pH 7.5     30 mM   Tris-HCl (pH 6.8)      0.3 M 
NaCl     150 mM   Glycerol     50    % 
EDTA        2 mM   SDS       5    % 
Triton X-100        1 % (v/v)   DTT       2    % 
CompleteTM (25x)     Pyronin Y      0.025 %  
H2O 
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Resolving gel (7.5%)    Stacking gel 
PAA solution 30%       5.6 ml   PAA solution 30%       2.6 ml  
1.5 M Tris, pH 8.8       5.6 ml   1.25 M Tris, pH 6.8       1.5 ml  
SDS 10%        0.3 ml   SDS 10%        0.2 ml 
TEMED      23.0 µl   TEMED      30.0 µl  
APS     112.5 µl   APS     150.0 µl 
H2O       11.0 ml   H2O       10.5 ml  
 
Electrophoresis buffer    Blotting buffer 
Tris Base     3.0 g   Tris Base    3.0 g 
Glycin    14.4 g   Glycin   14.4 g 
SDS      1.0 g   Methanol  20.0 % 
H2O         ad 1000 ml  H2O        ad 1000 ml 
 
TBS-T (pH 8.0) 
Tris-Base     3.0 g 
NaCl    11.1 g 
Tween 20     1.0 ml 
H2O         ad 1000 ml 
Adjust pH to 8.0 
 
10.1 Preparation of samples 
 
HUVECs cells were grown in 60 mm dishes until reaching confluency. Then cells were 
pre-incubated with MAB F7 for 2 h and subsequently stimulated with  TNF-α (5 ng/ml) 
for additional 16 h. After incubation cells were washed with PBS and incubated with 
300 µl lysis buffer for 30 min on ice. Thereafter cells were scraped with a rubber 
policeman and transferred to a pre-cooled reaction tube and sedimented for 10 min at 
14,000xg, 4°C. After determination of protein concentration by the method of Bradford 
(Bradford, 1976), an appropriate volume of sample buffer was added to the probes. 
After boiling at 95°C for 5 min, the samples were either stored at –20°C or immediately 
used for protein electrophoresis.  
 
10.2 Electrophoresis, blotting and detection of proteins 
 
Separation of proteins was performed by denaturating SDS-polyacrylamide gel (PAGE) 
electrophoresis (Laemmli, 1970). Samples with equal amount of protein and the 
molecular weight marker were loaded into the slots of the prepared polyacrylamid gels. 
Electrophoresis was run at 100 V for 21 min for stacking and at 200 V for 36 min for 
resolving of the proteins. After electrophoresis proteins were transferred to a nitro-
cellulose membrane (Amersham) at 150 V for 1 h. Then membranes were blocked with 
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10 % nonfat dry milk in TBS-T for 2 h at RT. Membranes were washed several times 
with TBS-T and incubated with primary polyclonal rabbit  antibody against human 
ICAM-1 (Santa Cruz; 1:500 in 1% nonfat dry milk in TBS-T) overnight at 4°C. On the 
next day membranes were washed several times with TBS-T and subsequently 
incubated with secondary horseradish peroxidase (HRPO)-labeled goat anti-rabbit IgG 
antibody (Jackson Laboratories; 1:10,000. in 1% nonfat dry milk in TBS-T) for 1 h. 
Chemiluminescence detection was performed using Western Blot Chemiluminescence 
Reagent Plus (NEN Life Science) and imaged by a Kodak Digital ScienceTM Image 
station 440CF (NEN Life Science). Band intensity was quantified by densitometry of 
immunoblots using  KODAK 1D software, version 3.5.4. 
 
10.3 Coomassie blue staining 
 
Coomassie blue staining was used for control of equal protein loading and effective 
blotting of PAGE-gels. 
 
Staining solution     Destaining solution  
Coomassie blue       0.3 %   Glacial acetic acid   10% (v/v)  
Glacial acetic acid     10.0 % (v/v)  Ethanol 96%    30% (v/v)  
Ethanol 96%      45.0 % (v/v)  H2O  
H2O  
  
After Western blotting, gels were shaken with staining solution for 45 min and 
subsequently destained with destaining solution three times for 15 min. Proteins 
remaining in the gel became visible as blue bands.  
 
11. Analysis of protein synthesis 
 
11.1 Expression of GFP-protein 
 
HEK 293 cells were transfected with pEGFP-N1 as described before (see II.7.5). After 
transfection cells were incubated with MAB F7 or CHX for 24 h. Expression of GFP 
was determined using fluorescent microscopy and subsequently quantified by flow 
cytometry. For FACS analysis cells were detached with 250 µl trypsin/EDTA. 
Digestion was stopped by addition of 750 µl DMEM + 10 % FCS. Cells were pelleted 
at 220 g, 10 min, the cell pellet was washed twice with PBS. Afterwards cells were re-
suspended in 400 µl PBS and analyzed by flow cytometry. GFP positive cells were 
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quantified at λem 530 nm (green fluorescence, FL-1) and λem 585 nm (red fluorescence, 
FL-2), after excitation at 488 nm with an argon laser. 
 
11.2  [3H]-Leucin incorporation 
 
HUVECs were seeded at a concentration of 5x104 cells/well in a 6-well plate and were 
grown for 24 h. Cells were incubated with various concentrations of MAB F7 or 
cycloheximide (CHX, Sigma) and 1µCi [3H]-leucine (Amersham) for 24 h. To test 
whether inhibitory effects are reversible cells were incubated with MAB F7 or CHX for 
24 h. Thereafter growth medium was changed and cells were incubated for additional 
24 h with 1µCi [3H]-leucine. After incubation with [3H]-leucine cells were washed 
twice with ice-cold PBS and subsequently protein was precipitated for 5 min with 5 % - 
trichloroacetic acid (Riedel-de-Haen). Afterwards cells were washed twice with ice-cold 
PBS and lysed with 0.4 N NaOH. 800 µl of the lysate were transferred to a scintillation 
tube and acidified with 200 µl 1N HCl. Then 5 ml scintillation liquid (Roth) were 
added. [3H]-leucine incorporation was quantified using a Beckman LS 6500 (Beckman). 
 
12. Statistics 
 
All data are expressed as mean and standard error, unless stated otherwise. The 
significance of differences between experimental groups was determined by one-way 
ANOVA with Bonferroni post-test or paired t-test. P<0.05 was considered statistically 
significant. Analysis of data was performed using the software GraphPad PRISM®, 
Version 3.02 (GraphPad Software Inc.). 
IV. Results 
 
1. Garlic (Allium sativum L.) 
 
1.1 Synthesis of allyl-methylsulfone 
 
 
S S
O O
H2O2 CH3COOH
+
0 °C
MW: 88 g/mol MW: 120 g/mol
 
 
Figure 10: Synthesis of allyl-methylsulfone 
 
9.1 mmol of allyl-methylsulfide (Acros Organics) was oxidized with 18.2 mmol 
hydrogenperoxide (H2O2) in 20 ml glacial acetic acid by stirring at 0 °C for 18 h. 
Afterwards the whole preparation was neutralized with saturated sodium bicarbonate 
solution (NaHCO3) and the products were extracted with ethyl-ether. The extracted 
products were identified by thin layer chromatography (solvent hexane:ethyl-ether 1:1 
and detected with potassium manganate (K2MnO4) in 1 N sulfuric acid (H2SO4)) and 
further separated by flash chromatography as described before (Still et al., 1978). As 
solvent a mixture of hexane:ethyl ether 1:1 was used. The purified substance was 
identified by mass spectrometry (120 U), 1H-NMR and 13C-NMR (see figure 11 & table 
6). 
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Figure 11: Mass-spectrogram of allyl-methy-sulfone 
Calculated molar weight of AMSO2 MG: 120 g/mol 
 
 
Group 13C (ppm) signal 1H (ppm) signal 
CH2 = 124 singulet 3,75 duplet 
= CH  125 singulet 5,98 multiplet 
 CH2  59 singulet 5,54 double-doublet 
 CH3 39 singulet 2,88 singulet 
 
 
Table 6: NMR-signals of allyl-methyl-sulfone 
 
1.2 Effect of sulfur-fertilization on total sulfur content and the content of 
sulfur compounds in dried garlic powder  
 
The total sulfur content in unfertilized garlic was 3091 ppm. With sulfur fertilization 
(CaSO4, 320 kg/ha) the amount of sulfur in garlic powders rose to 6097 ppm. Analysis 
of total sulfur content was performed by Dr. Laurence Trueman (HRI, Wellesbourne, 
U.K.). The distribution of sulfur in alliin, allicin, allyl-cysteine and γ-glutamyl-cysteines 
in dried garlic powders was assessed by HPLC analysis of the same powders. HPLC 
analysis was performed by T. Haffner at Lichtwer AG (Berlin, Germany). As can be 
seen in figure 12 sulfur-fertilization significantly increased detected allicin, alliin, γ-
glutamyl-1-propyl-cysteine and γ-glutamyl-phenylalanin levels. In contrast, the amount 
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of γ-glutamyl-allyl-cysteine remained unchanged and the level of allyl-cysteine was 
slightly reduced.  
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igure 12: Sulfur fertilization increases the content of sulfur compounds in dried garlic powder.  
lized 
1.3 Interaction of garlic with nuclear factor-kappa B (NF-κB) 
 order to investigate possible inhibitory effects of garlic on TNF-α-induced NF-κB 
F
The relative content of the following compounds in garlic powders of unfertilized or sulfur ferti
garlic, as indicated, was analyzed by HPLC-UV: allicin, alliin, γ-glutamyl-allyl-cysteine (γ-Glu-allyl-
Cys), γ-glutamyl-1-propyl-cysteine (γ-Glu-1-prop-Cys), γ-glutamyl-phenylalanin (γ-Glu-Phe), allyl-
cysteine (Allyl-Cys). Bars represent the mean ± SEM of two independent experiments. **P<0.01, 
***P<0.001 (paired t-test) 
 
In
activation, we investigated NF-κB DNA binding by electrophoretic mobility shift assay 
(EMSA) and NF-κB transactivation activity with a NF-κB-driven firefly-luciferase 
reporter gene assay. We used single garlic constituents, i.e. diallyl-disulfide, allyl-
mercaptane, S-allylcysteine, allyl-methylsulfone and γ-glutamyl-cysteine. Further we 
prepared hydrophilic and lipophilic extracts of garlic powders as described under 
methods. Solvent for hydrophilic extraction was RPMI-media and for lipophilic 
extraction DMSO. 
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1.3.1 Garlic metabolites do not inhibit TNF-α-activated NF-κB binding 
activity.  
 
Figure 13 demonstrates that TNF-α (10 ng/ml) activates DNA binding activity of NF-
κB, and that this binding activity is not considerably decreased in cells pre-treated with 
diallyl-disulfide (DADS) or allyl-mercaptane (AM) (5-20 µM).  
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Figure 13: Allyl-mercaptane and diallyl-disulfide do not inhibit TNF-α-induced NF-κB DNA binding 
activity. 
HUVECSs were either left untreated or were treated with DADS or AM as indicated. After 2 h TNF-α 
(10 ng/ml) was added for an additional hour. Equal amounts of nuclear extracts were employed to EMSA 
as described under Methods. The first two lanes of each gel show DNA binding of nuclear extracts of 
TNF-α-activated cells incubated with a 100-fold excess of an unlabeled NF-κB (unlabeled competitor, 
line 1) or AP-2 (unlabeled noncompetitor, line 2) consensus oligonucleotide. All experiments were 
performed at least three times. Representative gel shift experiments are shown.  
 
 
Similar results were obtained investigating γ-glutamylcysteine (1 nM-1 mM), a major 
constituent of whole and crushed garlic gloves (Lawson, 1996) and SAC (0.1-10 mM), 
a major sulfur constituent of aged garlic extract (Borek, 2001) as depicted in figure 14.  
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Figure 14: γ-Glutamylcysteine (γGC) and S-allylcysteine (SAC) do not inhibit TNF-α-induced NF-κB 
DNA binding activity. 
HUVECSs were either left untreated or were treated with γGC and SAC as indicated. After 2 h TNF-α 
(10 ng/ml) was added for an additional hour. Equal amounts of nuclear extracts were employed to EMSA 
as described under Methods. The first two lanes of each gel show DNA binding of nuclear extracts of 
TNF-α-activated cells incubated with a 100-fold excess of an unlabeled NF-κB (unlabeled competitor, 
line 1) or AP-2 (unlabeled noncompetitor, line 2) consensus oligonucleotide. All experiments were 
performed at least three times. Representative gel shift experiments are shown.  
 
In order to show the functionality of our test system we tested a known NF-κB 
inhibitor. HUVECSs were treated with the sesquiterpenlactone parthenolide, a well-
established NF-κB inhibitor (Hehner et al., 1999). Parthenolide concentration-
dependently (0.1-10 µM) inhibited NF-κB binding activity (figure 15). 
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Figure 15: Parthenolide inhibits TNF-induced NF-κB DNA binding activity 
HUVECSs were pre-treated with parthenolide for 2 h. Then cells were stimulated with 10 ng/ml TNF for 
1 h. Cells pre-treated with parthenolide showed strongly impaired NF-κB binding. Equal amounts of 
nuclear extracts were employed to EMSA as described under Methods. The first two lanes of each gel 
show DNA binding of nuclear extracts of TNF-α-activated cells incubated with a 100-fold excess of an 
unlabeled NF-κB (unlabeled competitor, line 1) or AP-2 (unlabeled noncompetitor, line 2) consensus 
oligonucleotide. All experiments were performed at least three times. A representative gel shift 
experiment is shown.  
 
1.3.2 Garlic metabolites do not inhibit TNF-α-activated NF-κB 
transactivation activity.  
 
Accumulating evidence indicate that NF-κB activity is not only dependent on 
translocation of p50/RelA into the nucleus, but also on direct modification of NF-κB 
proteins through phosphorylation and acetylation (Zhong et al., 1998; Zhong et al., 
2002; Chen et al., 2001). Therefore we established a NF-κB-driven firefly luciferase 
reporter gene assay to determine the actual transactivation activity of NF-κB.  
First, a time- and concentration-course (figure 16, figure 17) for TNF-α-induced  
NF-κB-dependent transcriptional activation was performed to establish the experimental 
procedure for further reporter gene assays. 
 
TNF-α induced NF-κB transactivation activity was monitored over 24 h. As depicted in 
figure 16, maximal luciferase activity was measured at 16 h. For our experiments we 
chose a stimulation time of 6 h to minimize possible cytotoxic effects that may emerge 
from test compounds in the presence of TNF-α. 
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Figure 16: Time course TNF-α 
Transfected HEK 293 cells were stimulated with 1ng/ml TNF-α for the indicated times. HEK 293 cells were 
transfected as described under Methods. Co represents luciferase activity of untreated cells. Bars 
represent mean ± SEM of three independent experiments performed in triplicate.**p<0.01 and 
***p<0.001 (ANOVA/Bonferroni). 
 
Luciferase activity increased dose-dependently with a maximum at 10 ng/ml TNF-α 
(figure 17). For our further experiments we chose 1 ng/ml TNF-α, in order to minimize 
cytotoxic effects of TNF-α. 
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Figure 17: Concentration course TNF-α 
Transfected HEK 293 cells were stimulated with the indicated concentrations of TNF-α for 6h. HEK 293 
cells were transfected as described under Methods. Co represents luciferase activity of untreated cells. 
Bars represent mean ± SEM of three independent experiments performed in triplicate.**p<0.01 and 
***p<0.001 (ANOVA/Bonferroni). 
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Of further interest was whether TNF-α-induced NF-κB transactivation activity could be 
inhibited by known NF-κB inhibitors. Therefore we investigated whether the known 
proteasome-inhibitor carbobenzoxyl-leucinyl-leucynil-leucynal (MG-132), and the 
sesquiterpenelactone parthenolide inhibit TNF-α-induced luciferase activity 
(Palombella et al., 1994; Hehner et al., 1999). 
Pre-treatment with the peptide-aldehyde MG-132 dose-dependently inhibited NF-κB 
transactivation at concentrations of 1 and 10 µM. Treatment with 0.1 µM showed no 
effect on TNF-α-induced NF-κB activity (figure 18). 
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Figure 18: MG-132 inhibits NF-κB transcriptional activity 
Transfected HEK 293 cells were pre-incubated with various concentrations of MG-132 for 2 h. Then cells 
were activated with 1 ng/ml TNF-α for 6h. Co represents luciferase activity of untreated cells. Bars 
represent mean ± SEM of three independent experiments performed in triplicates. ***p<0.001 
(ANOVA/Bonferroni). 
 
 
Pre-treatment with the sesquiterpenelactone parthenolide in concentrations of 0.1 µM to 
10 µ M also led to a dose-dependent inhibition of NF-κB (figure 19). 
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Figure 19: Parthenolide inhibits NF-κB transcriptional activity 
Transfected HEK 293 cells were pre-incubated with various concentrations of parthenolide for 2 h. Then 
cells were activated with 1 ng/ml TNF-α for 6h. Co represents luciferase activity of untreated cells. Bars 
represent mean ± SEM of three independent experiments performed in triplicate. *p<0.05, **<p0.01, 
***p<0.001 (ANOVA/Bonferroni). 
 
After finding optimal assay settings we investigated whether the garlic metabolites 
DADS, AM, AMSO2 and allicin influence the transactivation activity of NF-κB. 
Neither DADS (1-100 µM) nor AM (1-100 µM) affected TNF-α (1 ng/ml)-induced 
firefly-luciferase expression (figure 20, figure 21). AMSO2 and allicin showed similar 
results as DADS and AM (data not shown). 
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Figure 20: Allylmercaptane (AM) does not inhibit NF-κB transactivation activity  
HEK 293 cells were either left untreated or were pre-treated with AM  as indicated. After 2 h TNF-α (1 
ng/ml) was added for additional 6 h. Co represents luciferase activity of untreated cells. Bars represent 
the mean ± SEM of at least three independent experiments performed in triplicate.  
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Figure 21: Diallyl-disulfide (DADS) does not inhibit NF-κB transactivation activity 
HEK 293 cells were either left untreated or were pre-treated with DADS as indicated. After 2 h TNF-α (1 
ng/ml) was added for additional 6 h. Co represents luciferase activity of untreated cells. Bars represent 
the mean ± SEM of at least three independent experiments performed in triplicate.  
 
Additionally we tested whether various garlic powders-extracts have an impact on  
TNF-α-induced NF-κB transactivation. In detail we examined extracts of Morasol 0 & 
100, Morado 200, Printanor 0 & 200 (year 2000) and Printanor 0, 200, 400 & 2000 
(year 2001) from France and Spain (see page 18). Concentrations used for aqueous 
extracts were from 1 µg/ml to 1000 µg/ml, for DMSO extracts from 1 µg/ml to 500 
µg/ml. 
None of the tested extracts showed an inhibitory effect on TNF-α-induced NF-κB 
transcriptional activity. Depicted are two representative graphs in figure 22 and figure 
23. 
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Figure 22: Aqueous extract of Morado 200 does not inhibit NF-κB transactivation activity 
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HEK 293 cells were either left untreated or were pre-treated with aqueous extract of Morado 200 as 
indicated. After 2 h TNF-α (1 ng/ml) was added for additional 6 h. Co represents luciferase activity of 
untreated cells. Bars represent the mean ± SEM of at least three independent experiments performed in 
triplicate.  
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Figure 23: DMSO extract of Printanor 200 does not inhibit NF-κB transactivation activity 
HEK 293 cells were either left untreated or were pre-treated with DMSO extract of Printanor 200 as 
indicated. After 2 h TNF-α (1 ng/ml) was added for additional 6 h. Co represents luciferase activity of 
untreated cells. Bars represent the mean ± SEM of at least three independent experiments performed in 
triplicate.  
 
 
1.4 Interaction of garlic with adhesion molecules 
 
Of interest was further whether the main garlic metabolites DADS and AM mediate an 
inhibitory effect on the TNF-α-induced expression of adhesion molecules ICAM-1 and 
E-selectin. Analysis of cell-surface proteins was carried out by flow-cytometry. 
 
1.4.1 Garlic metabolites do not affect TNF-α-activated E-selectin 
expression. 
 
2 h pre-treatment of HUVECSs with DADS (5-20 µM) and AM (5-20 µM) does not 
inhibit TNF-α-induced E-selectin expression. DADS rather slightly increased E-selectin 
levels (figure 24). 
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Figure 24: DADS and AM do not inhibit the induction of the adhesion molecule E-selectin 
HUVECSs were either left untreated or were pre-treated with AM (A) or DADS (B) as indicated. After 2 h 
TNF-α (10 ng/ml) was added for additional 4 h. Expression of E-selectin was quantified by flow 
cytometry as described under Methods. Data in the left panels show representative histograms 
demonstrating numbers of cells vs. fluorescence intensity at 520 nm. Co represents E-selectin expression 
of untreated cells. Bars represent the mean ± SEM of at least three independent experiments performed in 
triplicate. * P < 0.05, ** P < 0.01 (ANOVA/Bonferroni). 
 
 
It was reported by Ide and Lau, 2001 that SAC pre-incubation for 24 h inhibited TNF-
α-induced NF-κB translocation. Therefore, we decided to extend the pre-incubation 
period to 24 h and to increase the amount of DADS and AM. Pre-treatment with DADS 
or AM up to 100 µM for 24 h also showed no effect on the expression E-selectin (figure 
25) 
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Figure 25: 24 h pre-incubation with DADS and AM do not inhibit the induction of E-selectin 
HUVECSs were either left untreated or were pre-treated with AM (A) or DADS (B) as indicated for 24 h. 
Afterwards TNF-α (10 ng/ml) was added for additional 4 h. Expression of E-selectin was quantified by 
flow cytometry as described under Methods. Data in the left panels show representative histograms 
demonstrating numbers of cells vs. fluorescence intensity at 520 nm. Co represents E-selectin expression 
of untreated cells. Bars represent the mean ± SEM of at least three independent experiments performed in 
triplicate. 
 
 
To demonstrate the functionality of our assay we performed experiments with the 
known NF-κB inhibitor parthenolide (0.1 – 10 µM). TNF-α-mediated expression of E-
selectin was significantly inhibited with 10 µM parthenolide (figure 26).  
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Figure 26: Parthenolide significantly inhibits induction of E-selectin 
HUVECSs were either left untreated or were pre-treated with parthenolide as indicated. After 2 h TNF-α 
(10 ng/ml) was added for additional 4 h. Expression of E-selectin was quantified by flow cytometry as 
described under Methods. Data in the left panel show a representative histogram demonstrating numbers 
of cells vs. fluorescence intensity at 520 nm. Co represents E-selectin expression of untreated cells. Bars 
represent the mean ± SEM of at least three independent experiments performed in triplicate. *** P < 
0.001 (ANOVA/Bonferroni). 
 
1.4.2 Garlic metabolites do not affect TNF-α-activated ICAM-1 
expression 
 
Pre-incubation with AM (5-20 µM) for 2 h (figure 27) was as ineffective in inhibiting 
TNF-α-induced expression of ICAM-1 as pre-treatment with DADS (1 – 100 µM) and 
AM (1 – 100 µM) for 24 h (figure 28). 
 
Fluorescence intensity
C
ou
nt
s
untreated
TNF-α
20 µM AM + TNF- α
0
25
50
75
100
125
Co 20  5          10 20        AM (µM)
 +           + +            +         TNF-α
Fl
uo
re
sc
en
ce
 in
te
ns
ity
(%
 o
f T
N
F)
Fl
uo
re
sc
en
ce
 in
te
ns
ity
(%
 o
f T
N
F)
 
Figure 27: AM does not inhibit the induction of ICAM-1 
HUVECSs were either left untreated or were pre-treated with AM as indicated. After 2 h TNF-α (10 
ng/ml) was added for additional 4 h. Expression of E-selectin was quantified by flow cytometry as 
described under Methods. Co represents ICAM-1 expression of untreated cells. Data in the left panel 
show a representative histogram demonstrating numbers of cells vs. fluorescence intensity at 520 nm. 
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Figure 28: 24 h pre-incubation with DADS and AM do not inhibit the induction of ICAM-1 
HUVECSs were either left untreated or were pre-treated with AM (A) or DADS (B) as indicated for 24 h. 
Afterwards TNF-α (10 ng/ml) was added for additional 16 h. Expression of ICAM-1 was quantified by 
flow cytometry as described under Methods. Data in the left panels show representative histograms 
demonstrating numbers of cells vs. fluorescence intensity at 520 nm. Co represents ICAM-1 expression of 
untreated cells. Bars represent the mean ± SEM of at least three independent experiments performed in 
triplicate. 
 
1.5 Interaction of garlic with cytokines 
 
The human immune system (e.g. leucocytes, monocytes and macrophages) reacts in the 
presence of even small amounts of LPS with massive liberation of cytokines, which can 
cause severe inflammatory response leading to sepsis, septic-shock or multi-organ 
failure (Ginsburg, 2002). Additionally, it has been shown that the transcription factor 
NF-κB is also involved in the LPS-induced liberation of cytokines (Guha and 
Mackman, 2001). Since garlic mediates anti-inflammatory effects, we were interested 
how garlic constituents or garlic extracts would influence cytokine liberation in an ex 
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vivo human whole blood model. We used garlic powders from fertilized and unfertilized 
garlic plants and prepared two different kinds of extracts. The solvents used were RPMI 
medium on the one hand as aqueous solvent and DMSO as lipophilic solvent on the 
other hand. 
 
1.5.1 Interaction of aqueous dry garlic powder extracts with cytokines 
 
We examined aqueous extracts made from fertilized or unfertilized garlic dry powders 
(aGPE) in final concentrations of 0.1 mg/ml and 1 mg/ml  (garlic powder/ml). Treatment of 
whole blood with 10 ng/ml LPS led to a strong liberation of the pro-inflammatory 
cytokines IL-1β and TNF-α (figure 29 A&B). Stimulation of human whole blood with 
aqueous garlic powder extract alone led to a dose-dependent liberation of the pro-
inflammatory cytokines IL-1β and TNF-α. Co-treatment with aGPE and LPS resulted in 
an additive increase of liberated pro-inflammatory IL-1β (figure 29A) and TNF-α 
(figure 29B). Similarly, anti-inflammatory cytokine IL-10 was liberated by garlic 
extracts alone. Blood samples co-treated with LPS and garlic showed higher amounts of 
IL-10, than samples treated with LPS alone (figure 29C). The liberation of cytokines by 
aqueous garlic extracts point to an endotoxin-like activity of aGPE. Interestingly, we 
found that treatment with an extract from sulfur-fertilized garlic showed lower 
stimulating effects alone or with LPS as an extract from unfertilized garlic. 
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Figure 29: Effect of aqueous garlic extracts on the  liberation of cytokines. 
Whole blood was incubated with the indicated concentrations of either aGPE alone or where indicated 
with 10 ng/ml LPS and subsequently incubated for 16 h. The levels of IL-1β (A), TNF-α (B) and IL-10 (C) 
were measured by ELISA as described under Methods. Co represents cytokine levels of untreated cells. 
Bars represent the mean ± SEM of values obtained from four healthy blood donors. ##P<0.01, 
###P<0.001 compared to Co; *P<0.05, ***P<0.001 compared to LPS (ANOVA/Bonferroni); +P<0.05, 
++P<0.01, +++P<0.001 compared to unfertilized garlic (paired t-test). 
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1.5.2 Interaction of DMSO dry garlic powder extract with cytokines 
 
Treatment of whole blood with 10 ng/ml LPS led to a strong liberation of the pro-
inflammatory cytokines IL-1β and TNF-α (figure 30A&B). Co-treatment with DMSO 
garlic powder extract (dGPE 10 and 100 µg/ml) resulted in a significant reduction of 
liberated IL-1β (figure 30A). Similarly, the amount of liberated TNF-α was 
significantly impaired compared to human whole blood treated with LPS only (figure 
30B). dGPE alone, in the absence of LPS, did not influence cytokine levels in human 
whole blood indicating that it possesses a low endotoxin-like activity. Additionally we 
found that an extract from sulfur-fertilized garlic inhibited LPS-induced TNF-α and IL-
1β release better than the extract of unfertilized garlic.  
LPS alone increased the expression of IL-10. Co-incubation with 10 or 100 µg/ml of 
dGPE showed no inhibitory effect on LPS-induced liberation of IL-10. In contrast, 
dGPE tended to increase IL-10 release (figure 30C). Since expression of IL-10 peaks 
later than the expression of TNF-α or IL-1β (Boneberg and Hartung, 2001; Boneberg 
and Hartung, 2001), it seems unlikely, that a cytotoxic effect of dGPE is responsible for 
the decreased TNF-α and IL-1β levels. Again dGPE alone did not affect IL-10 
production in the absence of LPS. Fertilization seems not to have a effect on IL-10 
liberation. 
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Figure 30: Effect of DMSO garlic extracts on the  liberation of cytokines. 
Whole blood was incubated with the indicated concentrations of either dGPE alone or where indicated 
with 10 ng/ml LPS and subsequently incubated for 16 h. The levels of IL-1β (A), TNF-α (B) and IL-10 (C) 
were measured by ELISA as described under Methods. Co represents cytokine levels of untreated cells. 
Bars represent the mean ± SEM of values obtained from four healthy blood donors. *P<0.05, **P<0.01, 
***P<0.001 compared to LPS (ANOVA/Bonferroni); +P<0.05, ++P<0.01 compared to unfertilized 
garlic (paired t-test). 
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1.5.3 Interaction of garlic constituents with cytokines 
 
In order to examine whether garlic constituents allicin, DADS, γ-Glu-Cys and AMSO2, 
contribute to the observed effects of GPE we employed all of the compounds in the 
whole blood assay system.  
Incubation of blood samples with LPS in the presence of DADS (1-100 µM) led to a 
significant reduction of Il-1β and TNF-α. Yet DADS showed no influence on LPS-
induced IL-10 release (figure 31). 
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Figure 31: Effect of DADS on cytokine levels 
Whole blood was incubated with various concentrations of DADS either alone or where indicated with 10 
ng/ml LPS and subsequently incubated for 16 h. The levels of IL-1β , TNF-α and IL-10  were measured 
by ELISA as described under Methods. Co represents cytokine levels of untreated cells. Bars represent 
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the mean ± SEM of values obtained from four healthy blood donors.  **P<0.01, ***P<0.001 
(ANOVA/Bonferroni). 
 
The major degradation product of alliin, allicin in concentrations up to 100 µM had no 
influence on IL-1β and TNF-α release and inhibited the liberation of IL-10 at a 
concentration of 100 µM (figure 32). 
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Figure 32: Effect of allicin on cytokine levels 
Whole blood was incubated with various concentrations of allicin either alone or where indicated with 10 
ng/ml LPS for 16 h. The levels of IL-1β , TNF-α and IL-10  were measured by ELISA as described under 
Methods. Co represents cytokine levels of untreated cells. Bars represent the mean ± SEM of values 
obtained from four healthy blood donors. **P<0.01 (ANOVA/Bonferroni). 
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AMSO2 a major metabolite of DADS (Germain et al., 2002) did not reduce Il-1β (figure 
33A), TNF-α (figure 33B) or IL-10 (figure 33C) liberation after LPS treatment. An 
other garlic constituent γ-glutamyl-cysteine (γ-GC) showed also no significant effect on 
the LPS-induced liberation of IL-1β (figure 33D), TNF-α (figure 33E) and IL-10 (figure 
33F) in human whole blood. 
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Figure 33: Effect of allyl-methyl-sulfone and γ-glutamyl-allyl-cysteine on cytokine levels 
Whole blood was incubated with various concentrations of AMSO2 or γ-GC either alone or where 
indicated with 10 ng/ml LPS for 16 h. The levels of IL-1β , TNF-α and IL-10 were measured by ELISA as 
described under Methods. Co represents cytokine levels of untreated cells. Bars represent the mean ± 
SEM of values obtained from four healthy blood donors. 
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1.6 Altered cytokine levels in human whole blood affect activation of  
NF-κB in HEK 293 cells. 
 
The crucial question was: would a dGPE-mediated reduction of pro-inflammatory 
cytokines, such as TNF-α and IL-1β, and slightly increased amounts of anti-
inflammatory IL-10 finally result in a reduced activation of NF-κB, and thus in a 
putative anti-inflammatory response. Incubation of transfected HEK 293 cells with cell-
free blood sample supernatants of LPS-activated whole blood increased the luciferase 
activity about 8-fold compared to the supernatants of untreated blood (figure 34A). 
dGPE-treated supernatants led to a significant reduced NF-κB activity corresponding to 
their lowered pro-inflammatory cytokine levels. In agreement with the results obtained 
from measuring cytokine levels, blood sample supernatants treated with fertilized garlic 
showed a stronger inhibitory effect than samples treated with unfertilized garlic (figure 
34A). To rule out that the observed result was due to a direct effect of dGPE (instead of 
modulated cytokine levels in blood samples) we pre-incubated transfected HEK 293 
cells with dGPE (10 or 100 µg/ml) and activated cells with TNF-α (1 ng/ml). As shown 
in figure 34B, dGPE had no direct inhibitory effect on TNF-α-induced expression of the 
NF-κB-driven luciferase reporter gene. 
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Figure 34: Garlic powder extract (dGPE)-treated and LPS activated blood samples induce lower NF-
κB activity than blood samples activated with LPS alone. 
(A) HEK293 cells were incubated for 6 h with 5 µl of cell-free supernatant from whole blood samples 
treated as indicated. (B) Cells were pre-incubated with GPE for 2 h and subsequently stimulated with 1 
ng/ml TNF-α for additional 6 h. Subsequently, a luciferase reporter-gene assay was performed. Co 
represents luciferase activity of cells treated with supernatant of untreated blood samples (A), or 
untreated cells (B) respectively. Bars represent the mean ± SEM, of at least three independent 
experiments performed in triplicate. *P<0.05, **P<0.01, ***P<0.001 (ANOVA/Bonferroni). 
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2. Edelweiss (Leontopodium alpinum Cass.) 
 
Edelweiss has been used by inhabitants of the Alps in traditional medicine for the 
treatment of bronchitis, fever and to cure inflammatory diseases of the gastrointestinal 
tract in man and animals (Bitschnau T., 1991; Kiene K., 1992b). We, therefore, focused 
on the possibly underlying molecular mechanisms of single constituents isolated from 
L.alpinum. We received bisabolane A, bisabolane CD and MAB F7 from Prof. Dr. H. 
Stuppner (University of Innsbruck, Austria). The constituents were isolated from roots 
of Leontopodium alpinum  Cass., the purity was found to be >98 % as judged by HPLC. 
All structures are depicted in figure 35. 
 
 
igure 35: Structure of constituents of Leontopodium alpinum Cass. 
2.1 Constituents of L. alpinum inhibit TNF-α-induced NF-κB 
 
2.1.1 Bisabolane A and bisabolane CD inhibit NF-κB transactivation. 
e started to examine whether Bisabolane A, CD or MAB F7 were able to inhibit TNF-
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W
α-mediated NF-κB transactivation. HEK 293 cells were transfected with pNF-κBluc 
and pRL-TK as described in Materials and Methods. Transfected cells were pre-
incubated with bisabolane A and bisabolane CD (1-100 µM) for 2 h. Subsequently cells 
were activated with 1 ng/ml TNF-α for 6 h. Bisabolane A as well as bisabolane CD 
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significantly inhibited TNF-α induced NF-κB transactivation in concentrations of 100 
µM (figure 36). Unfortunately, the observed effect was not dose-dependent and 
therefore we did not conduct further experiments with bisabolane A and bisabolane CD. 
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igure 36: Bisabolane A and bisabolane CD inhibit NF-κB-driven luciferase activity 
d bisabolane CD 
 
F
HEK 293 cells were pre-incubated with various concentrations of bisabolane A (A) an
(B) for 2 h. Afterwards cells were activated with 1 ng/ml TNF-α  for 6 h. Co represents luciferase activity 
of untreated cells. Bars represent mean ± SEM of three independent experiments performed in triplicate. 
*p<0.05, **p<0.01 (ANOVA/Bonferroni). 
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2.1.2 MAB F7 inhibits TNF-α-mediated NF-κB transactivation but not 
nuclear translocation and DNA-binding of NF-κB. 
 
Stimulation with 1 ng/ml TNF-α resulted in a strong increase of NF-κB activity. Pre-
treatment of transfected HEK 293 cells with MAB F7 for 2 h inhibited dose-dependent 
TNF-α activated NF-κB transactivation with a maximal inhibition at 50 µM. 50 µM of 
MAB F7 alone had no influence on NF-κB activity (figure 37). Since MAB F7 
exhibited a more effective and dose-dependent inhibition of NF-κB than Bisabolane A 
& CD, we focused on the mechanisms how MAB F7 mediates its effects. 
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Figure 37: MAB F7 inhibits TNF-α-mediated NF-κB-driven luciferase activity in HEK 293 
Transfected HEK 293 cells were pre-incubated with various concentrations of MAB F7 for 2 h. Then cells 
were activated with 1 ng/ml TNF-α for 6 h. Co represents luciferase activity of untreated cells. Bars 
represent mean ± SEM of three independent experiments performed in triplicate. ***p<0.001 
(ANOVA/Bonferroni). 
 
Next we tested whether this effect is due to a reduced DNA binding respectively an 
impaired nuclear translocation of NF-κB. For that reason we pre-treated HUVECS and 
Jurkat cells with MAB F7 for 2 h before stimulation with 5 ng/ml TNF-α for 30 min. 
Nuclear extracts were prepared and assayed for NF-κB-binding activity by EMSA. As it 
can be seen in figure 38 TNF-α led to a strong induction of NF-κB DNA binding, 
however MAB F7 did not inhibit DNA binding in neither HUVECS nor Jurkat cells. 
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Figure 38: MAB F7 does not impair TNF-α-mediated NF-κB DNA binding 
Left panel: HUVECSs or Jurkat were either left untreated or were treated with MAB F7 as indicated. 
After 2 h TNF-α (5 ng/ml) was added for additional 30 min. Equal amounts of nuclear extracts were 
employed to EMSA as described under Methods. The first two lanes of each gel show DNA binding of 
nuclear extracts of TNF-α-activated cells incubated with a 100-fold excess of unlabeled NF-κB 
(unlabeled competitor, line 1) or AP-2 (unlabeled noncompetitor, line 2) consensus oligonucleotides. All 
experiments were performed at least three times. Representative gel shift experiments are shown.  
Right panel: Quantitative evaluation of densitrometric data of all experiments. Co represent NF-κB 
DNA-binding activity of untreated cells. Bars represent the mean ± SEM of at least three independent 
experiments.  
 
We examined further the required incubation period to block NF-κB activation by 
MAB F7. Cells were incubated with MAB F7 for 2 h, 1 h, 30 min and 15 min before the 
addition of TNF-α, simultaneously with TNF-α, or 15 min, 30 min, 1 h, 2 h and 4 h 
after the addition of TNF-α. We found that MAB F7 inhibited NF-κB transactivation 
effectively until 2 h after the addition of TNF-α. However, when MAB F7 was added 4 
h after TNF-α, no effect on NF-κB activity was seen (figure 39). 
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Figure 39: MAB F7 still  inhibits NF-κB-driven luciferase activity 2 h after the addition of TNF-α 
Transfected HEK 293 cells were incubated with 50 µM MAB F7 for 2 h, 1 h, 30 min and 15 min before, at 
the same time (0 min), or 15 min, 30 min, 1 h, 2 h and 4 h after the addition of TNF-α (-15 min, -
30 min,…-4 h) . Cells were activated with 1 ng/ml TNF-α  for 6 h at time point 0 min. Co represents 
luciferase activity of untreated cells. Bars represent mean ± SEM of three independent experiments 
performed in duplicate. 
 
2.2 MAB F7 does not mediate cytotoxic effects in HUVECS 
 
In order to rule out that the effects seen are caused by cytotoxic side-effects, we 
incubated HUVECSs with 50 µM MAB F7 in the absence or presence of TNF-α for 24 
h. Cell viability was determined by propidium-iodide staining as described in Methods. 
Treatment of cells with MAB F7 had no significant effect on cell viability. Likewise, 
cells co-treated with TNF-α and MAB F7 were as viable as cells incubated with TNF-α 
alone (figure 40) 
 
igure 40: MAB F7 does not show cytotoxic effects after 24 h 
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represents the relative amount of dead untreated cells. Bars represent the mean ± SEM of three 
independent experiments performed in duplicate. 
 
2.3 MAB F7 inhibits the expression of ICAM-1 and E-selectin.  
 order to prove that MAB F7 affects NF-κB-regulated genes we examined whether the 
igure 41: MAB F7 inhibits the expression of ICAM-1 and E-selectin on the cell surface. 
 2 h TNF-α 
(5 ng/ml) was added for additional 4 h (E-selectin) or 16 h (ICAM-1), respectively. Expression of E-
 
 
In
TNF-α-induced expression of endothelial adhesion molecules ICAM-1 and E-selectin is 
inhibited by MAB F7. Stimulation of HUVECS with TNF-α increased ICAM-1 and E-
selectin expression on the cell surface. Surface expression of ICAM-1 and E-selectin 
was reduced to nearly basal levels by pre-treatment with 50 µM MAB F7 (figure 41). 
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F
HUVECSs were either left untreated or were pre-treated with MAB F7 as indicated. After
selectin and ICAM-1 was quantified by flow cytometry as described under Methods. Co represents 
adhesion molecules expressed on the surface of untreated cells. Data in the left panels show 
representative histograms demonstrating numbers of cells vs. fluorescence intensity at 520 nm. Bars 
represent the mean ± SEM of at least three independent experiments. ***P<0.01 (ANOVA/Bonferroni). 
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Additionally, we examined whether MAB F7 inhibits the TNF-α-induced expression of 
otal ICAM-1 in HUVECSs. Western blot analysis of whole cell lysates for ICAM-t 1 
 
 
igure 42: MAB F7 inhibits the TNF-α-induced expression of ICAM-1 
UVECSs were either left untreated or were pre-treated with MAB F7 as indicated. After 2 h TNF-α 
ion of untreated cells. The top 
ents. The lower diagram shows 
es not interfere with TNF-α-induced expression of  
ICAM-1 mRNA. 
In order to proof, that MAB F7 interacts with the NF-κB pathway and thereby reduces 
anscription of ICAM-1, we examined whether MAB F7 inhibits the TNF-α-induced 
revealed that co-treatment with TNF-α and 30 µM MAB F7 significantly increased 
ICAM-1 levels. However co-treatment with 50 µM MAB F7 led to a significant 
decrease of total ICAM-1 (figure 42). 
 
 
0.0
0.5
1.0
1.5 *
***
x-
fo
ld
 [T
NF
-α
]
MAB F7 (µM) 
TNFα
Co — 50 30    40    50
+     — +      +      +
x-
fo
ld
 [T
NF
-α
]
ICAM-1:
F
H
(5 ng/ml) was added for additional 16 h. Co represents ICAM-1 express
figure shows one representative western-blot of four independent experim
the densitrometric evaluation of all four experiments as mean ± SEM. *P<0.05, ***P<0.001 
(ANOVA/Bonferroni). 
 
2.4 MAB F7 do
 
tr
expression of ICAM-1 mRNA by real-time RT-PCR. Surprisingly, MAB F7 did not 
inhibit TNF-α-mediated expression of ICAM-1 mRNA. 10 µM MG-132, a well 
established NF-κB inhibitor, reduced the amount of ICAM-1 mRNA to 20 % (figure 
43). 
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Figure 43: MAB F7 does not interfere with TNF-α induced expression of ICAM-1 mRNA 
HUVECSs were pre-treated with MAB F7 or MG-132 as indicated and subsequently incubated for 4 h 
with 5 ng/ml TNF-α. ICAM-1 mRNA levels were determined by real-time RT-PCR. Normalization of 
ICAM-1 mRNA was performed by evaluating against 18s RNA levels. Bars represent the mean ± SEM of 
three independent experiments performed in triplicate. ***P<0.001 (ANOVA/Bonferroni). 
 
2.5 MAB F7 inhibits protein synthesis in HUVECS and HEK 293 cells. 
 
Since we now had the evidence that MAB F7 does not inhibit the TNF-α-mediated 
transcription of ICAM-1, we examined other mechanisms how MAB F7 could inhibit 
the TNF-α-induced expression of adhesion molecules. Since MAB F7 reduced E-
selectin and ICAM-1 levels as well as the activity of the firefly luciferase we decided to 
check whether MAB F7 inhibits protein synthesis in general. 
 
2.5.1 MAB F7 inhibits the expression of Pcmv-driven green fluorescent 
protein in HEK 293 cells. 
 
In order to demonstrate that the MAB F7-mediated inhibition of luciferase activity as 
demonstrated before (see III.2.1.2) was not due to a specific inhibition of NF-κB 
activity but rather due to an interference with protein synthesis, we transfected HEK 
293 with a plasmid containing a PCMV IE – driven green fluorescent protein. Right after 
the transfection procedure cells were incubated for 16 h with various concentrations of 
MAB F7. As positive control we used the known protein-synthesis inhibitor 
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cycloheximide (CHX) (Obrig et al., 1971). Expression of GFP-protein was determined 
by fluorescent microscopy. A representative field was chosen under normal light 
conditions (figure 44, left panel) and subsequently observed under UV-light (excitation 
wave-length: λex = 450 – 490 nm; emission wave-length: λem = 520 nm) (figure 44, 
middle panel). Treatment with MAB F7 led to a decreased expression of green 
fluorescent protein (figure 44 C&D), compared to untreated cells (figure 44 B). Cells 
treated with cycloheximide also showed impaired levels of GFP (figure 44E) 
Quantitative analysis of GFP-expression was carried out by flow cytometry. Dot-plot 
analysis of untransfected cells, as depicted in figure 46 (lane A, right panel), shows a 
unique population of cells, expressing a direct proportional increase in green 
fluorescence (FL-1H, λem =  530 nm) and red fluorescence (FL-2H, λem =  585 nm) after 
excitation with an argon-laser (λex = 488 nm). Since cells expressing GFP emit more 
green fluorescent light (FL-1H) than red fluorescent light (FL-2H), they can easily be 
detected and quantified as a second population as depicted in figure 46, lane B, right 
panel. Events lying in region R1 (figure 44, lane A, right panel) were considered as 
GFP-expressing cells. Quantitative analysis showed that MAB F7 dose-dependently 
reduces GFP expression. After treatment with 50 µM MAB F7 only 35 % of the GFP-
transfected cells expressed green fluorescent protein compared to untreated cells. CHX 
treatment decreased the expression of GFP to 30 % compared to untreated cells (figure 
45). 
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Figure 44: MAB F7 inhibits the expression of green fluorescent protein 
Left panel shows a representative field of untransfected or transfected HEK 293 cells observed by normal 
light. Middle panel shows the same field of transfected cells under UV-light (λex = 450 – 490 nm; λem = 
520 nm). Right panel shows dot-plots of HEK cells demonstrating red fluorescence (FL-2H: λem 585 nm) 
vs. green fluorescence (FL-1H: λem 530 nm). All events within region (R1) were considered as GFP-
expressing cells. Lane A represents cells not transfected with pEGFP-N1. Lane B: untreated transfected 
cells. Lane C: transfected cells treated with 30 µM MAB F7 for 16 h. Lane D: transfected cells treated 
with 50 µM MAB F7 for 16 h. Lane E: transfected cells treated with 25 µg/ml cycloheximide (CHX) for 
16 h. Representative pictures and dot-plots of three independent experiments performed in triplicate are 
shown. 
IV Results 71 
 
 
 
0
25
50
75
100
125
             30            50           MAB F7 [µM]
               25          CHX [µg/ml]
             +              +  +              +  pEGFP-N1
**
***
G
FP
 e
xp
re
ss
in
g 
ce
lls
[%
]
 
 
Figure 45: MAB F7 inhibits the expression of green fluorescent protein 
HEK 293 cells were either transfected with pEGFP-N1 or were left untreated. Transfected cells were 
incubated for 16 h with various amounts of MAB F7 or CHX as indicated. Bars represent the percentage 
of GFP-expressing cells. The number of untreated, transfected cells expressing GFP was set as 100 %. 
Values are represented as mean ± SEM of three independent experiments performed in triplicate. 
**p<0.01, ***p<0.001 (ANOVA/Bonferroni). 
 
2.5.2 MAB F7 inhibits [3H]-leucine incorporation in HEK 293 cells 
and HUVECS 
 
Since we could show that MAB F7 and CHX were able to decrease the expression of a 
CMV-driven GFP-reporter gene, we examined whether MAB F7 would also be able to 
reduce [3H]-leucine incorporation in HEK 293 cells. Therefore we co-incubated HEK 
293 cells with MAB F7 or CHX and [3H]-leucine (1µCi) for 24 h. As it can be seen in 
figure 46 treatment with MAB F7 reduced dose-dependently [3H]-leucine incorporation. 
Leucine uptake was reduced to 10 % by 50 µM MAB F7. CHX treated cells 
incorporated only 4 % leucine compared to untreated cells. 
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Figure 46: MAB F7 inhibits [3H]-leucine incorporation in HEK 293 cells 
HEK 293 cells were co-incubated for 24 h with MAB F7 and 1µCi [3H]-leucine as indicated. The 
incorporated radioactivity was determined with a liquid scintillation counter. Co represents leucine 
uptake in 24 h of untreated cells, set as 100 %. Bars represent the mean ± SEM of three independent 
experiments performed in triplicate. ***P<0.001 (ANOVA/Bonferroni). 
 
Furthermore we examined whether HUVECS incorporate less leucine after MAB F7 
treatment and whether this effect was reversible. We co-incubated HUVECS with MAB 
F7 and [3H]-leucine for 24 h. To investigate the reversibility of this effect we incubated 
the cells with MAB F7 for 24 h. After that period we removed the old medium washed 
the cells and added fresh medium with 1µCi [3H]-leucine and incubated them for 
additional 24 h. MAB F7 inhibited dose-dependently leucine integration. HUVECSs 
treated with 50 µM MAB F7 incorporated only 2 % leucine compared to control cells. 
This effect seems to be reversible: cells treated with 30 µM MAB F7 integrated 4 times 
more leucine  when MAB F7 was removed than cells co-treated with MAB F7. Cells 
treated with 50 µM MAB F7 incorporated 8 times more leucine after removal of MAB 
F7. However, the overall uptake is still significantly lower than that of control cells. 
CHX showed similar effects as MAB F7 (figure 47). 
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Figure 47: MAB F7 reversibly  inhibits [3H]-leucine incorporation in HUVECSs 
Light grey bars represent HUVECSs co-incubated for 24 h with MAB F7 or CHX and 1µCi [3H]-leucine. 
Black bars represent HUVECS incubated for 24 h with MAB F7 or CHX followed by medium change and 
1µCi [3H]-leucine incubation for additional 24 h. Co represents leucine uptake in 24 h of untreated cells, 
set as 100 %. The incorporated radioactivity was determined with a liquid scintillation counter. Bars 
represent the mean ± SEM of three independent experiments performed in triplicate., ***p<0.001 (light 
grey bars compared to Co); ###p<0.001 (dark grey bars compared to Co) (ANOVA/Bonferroni); 
++p<0.01, +++p<0.001 (paired t-test) 
 
 
 
V. Discussion 
 
Since the early 1990s’ it is widely accepted, that atherosclerosis is not just a simple 
occlusion problem caused by a growing deposit of blood-lipids that eventually closes an 
affected blood vessel (Libby, 2002). More and more evidence have demonstrated that 
atherosclerosis is a progressive inflammatory disease. It has been demonstrated that 
active nuclear factor-kappa B (NF-κB) is present in atherosclerotic lesions (Brand et al., 
1996). NF-κB plays an important role in the development of atherosclerosis by inducing 
the expression of cellular adhesion molecules (CAM), such as intercellular adhesion 
molecule-1 (ICAM-1) and E-selectin (Chen et al., 1995), chemokines like monocyte 
chemoattractant protein-1 (MCP-1) and IL-8, or cytokines TNF-α and IL-1β (Collins 
and Cybulsky, 2001). High amounts of adhesion molecules are expressed in areas of the 
atherosclerotic lesions, where an increased accumulation of leukocytes can be detected 
(O'Brien et al., 1996). The cytokine tumor necrosis factor alpha (TNF-α) is a strong 
enhancer for both NF-κB activation and CAM expression (Haraldsen et al., 1996). 
Since garlic has a long tradition as a medical plant with assumed anti-inflammatory 
properties we examined in the first part of the present work the influence of garlic on 
TNF-α-induced activation of NF-κB and CAM expression. 
 
 
1. Anti-inflammatory properties of garlic (Allium 
sativum L.) 
 
1.1 Garlic does not affect TNF-α-induced NF-κB activity and expression 
of ICAM-1 and E-selectin. 
 
We found that none of the different garlic extracts and the various single garlic 
compounds (i.e. DADS, AM, γ-GC, allicin, SAC or AMSO2), showed significant 
inhibitory effects on TNF-α induced NF-κB activity in a human embryonic kidney cell 
line (HEK 293) or in human endothelial cells (HUVECS). However, it has been 
described recently that pre-treatment with SAC is able to inhibit TNF-α-induced, and 
hydrogen peroxide-induced NF-κB activation in endothelial cells and T-cells (Geng et 
al., 1997; Ide and Lau, 2001; Ho et al., 2001). Yet, these results were achieved after a 
pre-incubation period of 24 h with concentrations of SAC in a milli-molar range. 
Whether these conditions can be reached in human plasma is questionable (Koch, 1996; 
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Rosen et al., 2001). Further, it is probable that these effects are not mediated by a 
specific inhibition of NF-κB by SAC. It seems more likely that cysteine as metabolite of 
SAC mediates this effect. As it has been described previously, cysteine and N-acetyl-
cysteine are capable to inhibit NF-κB activation by modulating the levels of 
intracellular glutathione and glutathione disulfide (Mihm et al., 1995; Oka et al., 2000).  
The TNF-α-mediated expression of ICAM-1 and E-selectin in HUVECS was not 
affected by DADS and AM treatment. This is supported by an in vivo study where it 
was shown that aged garlic extract (AGE) does not influence the expression of 
endothelial adhesion molecules or the adherence of leukocytes to the endothelium in 
rabbits on a cholesterol-enriched diet (Campbell et al., 2001). However, recently 
another group reported that garlic extracts are able to reduce leukocyte migration 
through endothelial monolayers in vitro (Hofbauer et al., 2001). These contradictory 
results can be due to the different garlic preparations and the different test systems used 
by each individual group. However, it can not be excluded that other transcription 
factors, important for the activation of ICAM-1, like AP-1, Ets-1, STAT or Sp1 are 
targeted by garlic. Likewise garlic may prevent the adhesion of leukocytes after 
stimulation with different agents, e.g. oxLDL, INF-γ (Roebuck and Finnegan, 1999; 
Dwivedi et al., 2001). Especially for aged garlic extract (AGE) it has been 
demonstrated, that it is capable to reduce LDL oxidation in vitro and in vivo and may 
contribute to decrease the expression of adhesion molecules by anti-oxidative effects 
(Munday et al., 1999; Lau, 2001; Borek, 2001).  
 
1.2 Garlic inhibits NF-κB activity via a modulation of cytokine release in 
human whole blood 
 
1.2.1 Garlic extracts modulate LPS-induced liberation of inflammatory 
cytokines in human whole blood. 
 
The liberation of pro- and anti-inflammatory cytokines of blood cells, i.e. monocytes, T-
cells and other lymphocytes is a further important factor in the process of inflammation 
(Cotran et al., 1999). Up to now very little is known about the interrelationship of garlic 
and cells of the immune system.  
We could show that DMSO extracts of dried garlic powders inhibit the LPS-induced 
liberation of the pro-inflammatory cytokines IL-1β and TNF-α. In parallel, the levels of 
the anti-inflammatory cytokine IL-10 remained unchanged or even tended to be 
increased. These findings are basically in line with a recent publication using fresh 
garlic juice (Ghazanfari et al., 2000; Hodge et al., 2002). However, in contrast to this 
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study, we were unable to detect an influence on the cytokines INF-γ and IL-6. This may 
be due to the different garlic preparations used (fresh garlic juice versus garlic powder 
extract) and different experimental set-ups. LPS is a strong inducer of various 
transcription factors, like NF-κB or AP-1 in monocytes (Guha and Mackman, 2001). 
Recent studies revealed that garlic extracts and SAC are capable to inhibit NF-κB 
activation after stimulation with LPS and INF-γ in mouse macrophages (Kim et al., 
2001). Interestingly the inhibitory effect of SAC after LPS and INF-γ stimulation was 
evident at 250-fold lower concentrations than described for TNF-α-stimulated cells 
(Geng et al., 1997). This indicates that garlic-mediated effects are dependent on the 
used stimulus and cell type. 
On the other hand, we could show that aqueous garlic extracts can act as strong inducers 
of IL-1β, TNF-α and IL-10 in human whole blood. This finding is supported by recent 
studies using the garlic constituent alliin or aged garlic extract. These studies show an 
increase of pro-inflammatory cytokine IL-1β, IL-2, IL-12, INF-γ and TNF-α in blood 
monocytes and spleen cells (Salman et al., 1999a; Kyo et al., 2001). Additionally, it was 
demonstrated that treatment with aqueous garlic extracts increased the concanavalin A-
induced (Con A) proliferation of T-lymphocytes stronger than ethanolic garlic extracts. 
This finding is correlated with increased IL-2 and IL-4 secretion (Colic et al., 2002; 
Kyo et al., 2001). These effects may be provoked by immunological active lectins 
within the different garlic preparations (Dam et al., 1998; Morioka et al., 1993). 
 
An attempt to identify the effective constituents of GPE was made by employing allicin 
and DADS, two major conversion products of alliin after its interaction with alliinase. 
Allicin had no inhibitory effect on the production of IL-1β and TNF-α, but rather 
decreased IL-10 levels. DADS decreased the LPS-induced release of TNF-α and IL-1β 
already at low concentrations (1 µM) and may thus contribute at least to the observed 
effect for GPE. AMSO2 and γ-GC had no effect on LPS-induced cytokine release.  
 
1.2.2 Modulation of cytokine release inhibits NF-κB activity in 
HEK 293 cells. 
 
Most interestingly, we showed that stimulation of HEK 293 cells with blood 
supernatants treated with garlic powder extracts and LPS resulted in a significantly 
lowered NF-κB activity compared to cells incubated with LPS-treated blood 
supernatants. The inhibition of NF-κB correlated very well with the reduced levels of 
IL-1β and TNF-α measured in the blood supernatants. TNF-α and IL-1β are two major 
cytokines that mediate inflammation and are involved in the progression of 
atherosclerotic lesions. Especially the activation of the endothelium, via NF-κB, is 
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induced by these two cytokines (McGill et al., 1998). In recent years the possibility that 
infections, combined with other factors, can be responsible for the genesis of the 
atherosclerotic lesions has been rediscovered (O'Connor et al., 2001). By suppressing 
the LPS-induced liberation of IL-1β and TNF-α garlic may inhibit the genesis of 
atherosclerosis. 
 
In summary, we could show that possible anti-atherogenic effects mediated by single 
garlic constituents or garlic extracts are not mediated via direct inhibition of NF-κB or 
NF-κB regulated genes. Moreover, it seems that modulation of cytokine release in blood 
cells may be the key of garlic-induced NF-κB inhibition. 
 
1.3 Modulation of cytokine-release and subsequent NF-κB inhibition by 
garlic is sulfur dependent. 
 
Further we could demonstrate that sulfur-fertilization of garlic plants leads to an 
increase in total sulfur and an increase in alliin, allicin, allyl-cysteine and γ-glutamyl-
cysteines in garlic dry powder. Extracts from sulfur-fertilized garlic inhibited IL-1β and 
TNF-α release more efficiently than unfertilized garlic. Additionally, stimulation of 
HEK cells with supernatants treated with sulfur-fertilized dGPE resulted in lower NF-
κB activity than dGPE of unfertilized garlic. In earlier studies the quality of the garlic 
powders used was often neglected, which could be one reason of the achieved 
contradictory results concerning a beneficial effect of garlic (Isaacsohn et al., 1998; 
Reuter et al., 1996). Moreover, the presented data point to sulfur-compounds as active 
principle of garlic with respect to the modulation of LPS-induced cytokine levels. This 
is an important finding as until now not much attention has been paid to sulfur-
fertilization during the cultivation of garlic as medicinal product. These findings are in 
line with recently published results of the sulfur-dependent anti-platelet activity of 
onions (Goldman et al., 1996).  
 
For the first time we could show, that inhibition of LPS-induced liberation of pro-
inflammatory cytokines IL-1β and TNF-α is dependent on the sulfur content of garlic 
powders used. 
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2. Anti-inflammatory properties of the edelweiss 
constituent MAB F7 
 
Edelweiss preparations were used as cure against inflammatory maladies of the gastro-
intestinal tract and bronchitis (Pickl-Kerk, 1995; Bitschnau, 1991). Since the 
transcription factor NF-κB and the adhesion molecules ICAM-1 and E-selectin 
represent important factors in the process of inflammation, we supposed that 
constituents of edelweiss mediate their anti-inflammatory properties by inhibition of 
NF-κB activity and thereby reduce the expression of adhesion molecules.  
 
2.1 Effects of MAB F7 on mediators of inflammation 
 
At first our attention was turned towards possible effects of edelweiss constituents on 
TNF-α-induced NF-κB transactivation activity. In a reporter-gene assay we could 
demonstrate the dose-dependent reduction of NF-κB transactivation by MAB F7, 
bisabolane A and bisabolane CD. Yet, we showed by electrophoretic mobility shift 
assay (EMSA) that MAB F7 was not able to inhibit TNF-α-mediated NF-κB DNA-
binding activity in HUVECS and Jurkat T-cells. The contradictory results can be 
explained by the fact that the activity of NF-κB is not only dependent on the DNA 
binding of NF-κB dimers, but also on direct modifications of NF-κB proteins (Zhong et 
al., 2002; Chen et al., 2001; Wang and Baldwin, 1998; Sakurai et al., 1999). It has been 
demonstrated that protein kinase A (PKA) can increase NF-κB activity by 
phosphorylation of p65. This increase is associated with an enhanced recruitment of the 
transcriptional co-activator CBP/p300 (Zhong et al., 1998). Further it was shown by 
Chen et al, that CBP/p300 acetylates p65. Acetylation of p65 prevents the binding to 
IκB and thus the IκB-dependent export of NF-κB (Chen et al., 2001). 
 
Secondly, we revealed by FACS analysis and western blot, that MAB F7 inhibited dose-
dependently the TNF-α-mediated expression of ICAM-1 and E-selectin in HUVECS. 
Ahn and colleagues showed recently that lignans from Magnoliae fargesii inhibited the 
TNF-α-induced expression of ICAM-1 and VCAM-1 in the human leukemic monocyte 
cell-line THP-1 (Ahn et al., 2001).  
In order to close the gap between NF-κB activation and the expression of adhesion 
molecules we performed real-time RT-PCR experiments. We could show that pre-
treatment of HUVECS with MAB F7 does not inhibit the TNF-α-induced expression of 
ICAM-1 mRNA. 
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The inhibitory effect of plant lignans on NF-κB seems to be strongly dependent on the 
chemical structure of the lignan, the cell-line and on the stimulus used. For example, it 
has been reported, that arctigenin a dibenzylbutyrolactone type lignan, inhibits LPS-
induced NF-κB activation in RAW macrophages (Cho et al., 2002). Further it was 
demonstrated by Baumann et al., that 1H-cyclopenta[b]benzofuran lignans 
(rocaglamides) from Aglia species inhibit NF-κB activity after TNF-α and PMF 
stimulation in T lymphocytes but not in HeLa and PC12 cells (Baumann et al., 2002). 
Both groups showed that IκBα levels were increased after treatment with the various 
lignans. Interestingly another transcription factor, i.e. SP-1 was not affected (Baumann 
et al., 2002). This stands in contrast to a recent study showing that the lignan Malachi 4 
inhibits the replication of human immunodeficiency virus type 1 (HIV-1). This effect is 
not mediated by inhibition of NF-κB but of SP-1 (Gnabre et al., 1995). 
 
Taken together, our results suggest that MAB F7 inhibits the TNF-α mediated 
expression of ICAM-1 and E-selectin not via the NF-κB pathway. 
 
2.2 Effects of MAB F7 on protein synthesis 
 
The fact that MAB F7 did inhibit the expression of firefly-luciferase protein, ICAM-1 
and E-selectin led us to the assumption that this effect might be linked with inhibition of 
protein synthesis. This hypothesis was confirmed by the finding that MAB F7 inhibited 
dose-dependently the incorporation of [3H]-leucine in HEK 293 cells and HUVECs. For 
HUVECs we could show that this effect seems to be reversible. However, leucine 
uptake was still significantly reduced 24 h after removal of MAB F7, pointing to a long 
persisting interference with protein synthesis. Secondly, we could show, that MAB F7 
blocked the expression of CMV-driven GFP-protein in HEK 293 cells. This supports 
the results we obtained with the leucine uptake and indicates that MAB F7 inhibits the 
protein synthesis of reporter genes, regardless of the used promoter. Additionally, this 
result explains how MAB F7 reduced the activity of the firefly luciferase reporter, even 
2 h after TNF-α stimulation. Previously, it has been shown that proliferation of 
endothelial cells occurs mainly at branch orifices, where atherosclerosis is initiated 
(Wright, 1972; Kunz et al., 1978). Akimoto and colleges demonstrated that laminar 
shear stress induces a reversible cell cycle arrest in G1-phase by the up-regulation of 
p21 (Akimoto et al., 2000). Besides, the authors suggest that increased cell proliferation 
might destabilize the endothelium and may cause atherosclerosis. Therefore, it is 
tempting to speculate that the MAB F7-induced reduction of cell proliferation may help 
to stabilize the endothelium. 
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These results are conclusive with other studies demonstrating anti-proliferative effects 
of various plant lignans on macrophage cell lines and breast cancer cell lines (Filleur et 
al., 2001; Cho et al., 2001a; Bohnenstengel et al., 1999). Other effects of lignans 
reported by various groups, such as the inhibition of NO-synthase expression (Cho et 
al., 2002) and NO production (Cho et al., 2001a), the release of TNF-α, IL-1α and IL-
1β (Yesilada et al., 2001; Cho et al., 2001a; Cho et al., 2001b) and inhibition of platelet 
aggregation (Chen et al., 2000) may be a result of the anti-proliferative effect. 
 
In summary we could show that MAB F7 blocks the TNF-α-induced expression of E-
selectin and ICAM-1 in human endothelial cells. This effect is not mediated by a 
specific inhibition of NF-κB activation as demonstrated by EMSA and real-time RT-
PCR. We showed that MAB F7 mediates a reversible block of protein synthesis in 
endothelial cells without altering cell viability. 
 
 
VI. Summary 
 
The present work examined molecular pathways involved in the proposed anti-
inflammatory properties of garlic (Allium sativum L.) and edelweiss (Leontopodium 
alpinum Cass.).  
 
Single garlic constituents and metabolites, i.e. diallyl disulfide (DADS), allyl 
mercaptane (AM), allyl methylsulfone (AMSO2), γ-glutamylcysteine (γGC) and S-
allylcysteine (SAC) failed to inhibit TNF-α-mediated activation of nuclear factor-κB 
(NF-κB) in HUVECs and HEK 293 cells. Hydrophilic and lipophilic extracts of various 
dried garlic powders had also no effect on NF-κB activation. 
As a consequence of this, DADS and AM also failed to inhibit the TNF-α-induced 
expression of adhesion molecules ICAM-1 and E-selectin. 
 
DMSO garlic extracts (dGPE) inhibited the LPS-induced liberation of pro-inflammatory 
cytokines IL-1β and TNF-α in a human ex vivo whole blood model, whereas the 
liberation of the anti-inflammatory cytokine IL-10 remained unchanged. The observed 
effect proved to be sulfur-dependent, since garlic powders fertilized with 200 U of 
sulphate (~ 320 kg CaSO4/ha) significantly reduced IL-1β and TNF-α release after LPS 
stimulation. From all single garlic constituents tested only DADS reduced IL-1β and 
TNF-α release. Allicin diminished IL-10 release, and AMSO2 and γGC where 
completely ineffective. 
 
Treatment of HEK 293 cells with dGPE and LPS-activated blood supernatants lowered 
NF-κB activity compared to cells treated with LPS-activated supernatants. The blood 
supernatants treated with sulfur-fertilized garlic showed again lower NF-κB activity as 
their unfertilized counterparts. This may be a possible mechanism, contributing to the 
anti-inflammatory effects of garlic. 
 
We showed for the first time that sulfur-fertilization of garlic augments the anti-
inflammatory actions of garlic powder extracts. This increase is correlated with 
enhanced levels of sulfur constituents in garlic dry powder. 
 
MAB F7 a lignan from L. alpinum inhibited the TNF-α-induced expression of the 
adhesion molecules ICAM-1 and E-selectin via a general inhibition of protein synthesis. 
It could be excluded that MAB F7 interferes directly with the NF-κB pathway. 
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In summary, this thesis work supplies new insights in the proposed anti-inflammatory 
actions of garlic extracts and constituents. It reveals that sulfur-fertilization of garlic 
plants may contribute to the improvement of garlic as medical plant. In addition, it 
provides first informations on the molecular actions of MAB F7, a lignan from 
edelweiss. To what extend these effects contribute to the postulated anti-inflammatory 
properties of L. alpinum remains unclear and is subject of further investigation. 
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Figure 48: Summary of the postulated effects. 
Garlic (Allium sativum L.) inhibits LPS-induced liberation of IL-β  and TNF-α in human whole blood 
leading to an overall impaired NF-κB activation in adjacent tissue. Edelweiss (Leontopodium alpinum 
Cass.) inhibited TNF-α-induced E-selectin and ICAM-1 expression by interfering with protein synthesis. 
 
 
The present studies about garlic were part of the EU Garlic & Health project supported 
by the European Community. 
(QLK1-CT-1999-00498; www.plant.wag-ur.nl/projects/garlicandhealth). 
 
VII. Appendix 
1. Abbreviations 
 
AGE    Aged garlic extract 
aGPE    Aqueous garlic powder extract 
AM    Allylmercaptane 
AMS    Allyl methylsulfide 
AMSO2   Allyl methylsulfone 
AP-1/2   Activator protein 1/2  
ApoB    Apolipoprotein B 
APS    Ammonium persulfate  
ATP    Adenosine-5’-triphosphate 
Bq    Bequerel  
BSA    Bovine serum albumine  
CAM    Cell adhesion molecule  
CBP    CREB binding protein 
cDNA    complementary DNA  
CHX    Cycloheximide 
cpm    Counts per minute  
CRE    cAMP-responsive enhancer-binding protein 
cRNA    complementary RNA  
Ci    Curie (1 Ci = 3.7x1010 Bequerel)      
Co    Control  
Da    Dalton  
DADS    Diallyl disulfide 
dGPE     DMSO garlic powder extract 
DLR    Dual luciferase reporter gene assay 
DMSO   Dimethylsulfoxide  
DNA    Desoxyribonucleic acid  
dNTP    Desoxynucleosidtriphosphate  
DTT    Dithio threitol  
ECGM   Endothelial cell growth medium 
ECL    Enhanced chemoluminescence reagent  
EDTA    Ethylene diamine-N,N,N´,N´ tetra acid  
EGTA    Bis(aminoethyl)glycolether-N,N,N´,N´-tetra acid  
EMSA    Electrophoretic mobility shift assay  
END    Enterodiol 
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ENL    Enterolactone 
FITC    Fluoresceinisothiocyanate  
FCS    Fetal calf serum  
G-CSF    Granulocyte-colony stimulating factor 
GFP    Green fluorescent protein 
GM-CSF   Granulocyte macrophage-colony stimulating factor 
γ-GC    γ-glutamylcysteine 
H    Hour  
HBS    HEPES buffered saline solution 
HDAC    Histone deacetylase 
HDL    High density lipoprotein 
HEK 293   Human embryonic kidney cell line 293 
HEPES N-[2-Hydroxyethyl]piperazine- 
N’-[2-ethanesulphonic acid] 
HIV-1    Human immunodeficiency virus type-1 
HUVECs   Human umbilical vein endothelial cells  
ICAM    Intracellular cell adhesion molecule  
IκB (-α/-ε)   Inhibitory protein (-α/-ε) 
IKK    IκB-kinase 
IL    Interleukin 
INF    Interferone 
JNK    c-Jun N-terminal kinase 
L    Liter  
LB    Lennox Broth 
LDL    Low density lipoprotein 
LPS    Lipopolysaccharide 
m    Milli (10-3)  
M    Molar  
MAB F7 2-methyl-but-2-enoic acid 4-(3,4-dimethoxy-benzyl)-2- 
(3,4-dimethoxy-phenyl)-tetrahydro-furan-3-ylmethylester 
MAT    Matairesinol 
MCP    Monocyte chemoattractant protein 
M-CSF   Macrophage-colony stimulating factor 
MG-132   Carbobenzoxyl-leucinyl-leucinyl-leucynal 
µ    Micro (10-6)  
min    Minute   
MOPS    3-[N-Morpholino]propansulfonic acid 
mRNA   messenger Ribonucleinic acid  
NEMO   NF-κB essential modulator 
NES    Nuclear export signal 
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% (m/v)   Mass per volume per cent  
n    Nano (10-9)  
NF-κB    Nuclear factor kappa B  
OD    Optical density  
oxLDL   Oxidised low density lipoprotein 
PAA    Polyacrylamide  
PAGE    Polyacrylamide-gel electrophoresis  
PBC    Peripheral blood cells 
PBS    Phosphate buffered saline solution  
PCR    Polymerase chain reaction  
PI    Propidium iodide 
PMSF    Phenylmethylsulfonylfluoride  
Poly[dIdC]    Polydesoxyinosine-desoxycytosine  
ppm    Parts per million 
RNA    Ribonucleinic acid  
RNAse   Ribonuclease  
rpm    Rotations per minute  
RT    Room temperature  
SAC    S-allylcysteine 
sec    Second  
SECO    Secoisolariciresinol 
SEM    Standard error of the mean value  
SDS    Sodium dodecyl sulfate  
SMC    Smooth muscle cells  
SRE    Serum response element 
STAT    Tignal transducers and activators of transcription 
STE    Sodium chloride, Tris, EDTA buffer  
TAE    Tris, acetate, EDTA buffer  
TBE    Tris, borate, EDTA buffer with Triton X-100  
TBS-T    Tris buffered saline solution with Tween  
TGF    Transforming growth factor 
TE    Tris-EDTA buffer  
TEMED   N,N,N´,N´-tetramethylethylendiamine  
TNF-α    Tumor necrosis factor alpha  
tot RNA   total RNA  
Tris    Tris-hydroxymethyl-aminomethan  
U    Unit  
V    Volt  
VCAM   Vascular Cell Adhesion Molecule  
% (v/v)   Volume per volume   
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W    Watt  
 
2. Alphabetical order of companies 
 
Acros Organics   (Schwerte, Germany) 
Amersham    (Braunschweig, Germany)  
Beckmann Instruments  (Munich, Germany)  
Becton Dickinson   (San Jose, CA, USA)  
Biochrom    (Berlin, Germany)  
BioRad Laboratories   (Munich, Germany)  
Biosource    (Nivelles, Belgium)  
Bio Whittaker Bioproducts  (Heidelberg, Germany)  
Berthold    (Bad Wildbad, Germany) 
Calbiochem    (Schwalbach, Germany)  
Carl Roth    (Karlsruhe, Germany)  
Clontech    (Palo Alto, CA, USA) 
Dianova    (Hamburg, Germany)  
Endogen    (Bonn, Gemany) 
Gibco/BRL    (Eggenstein, Germany)  
GraphPad Software   (San Diego, CA, USA) 
Greiner    (Nürtingen, Germany)  
ICN Biomedicals   (Eschwege, Germany)  
Jackson Immunolab   (Hamburg, Germany)  
MBI Fermentas   (St.Leon Roth, Germany) 
NEN     (Cologne, Germany)  
PAA Laboratories   (Linz, Austria) 
PAN     (Aidenbach, Germany)  
Packard    (Rodgau - Jügesheim, Germany) 
PE Applied Biosystems  (Foster City, CA, USA) 
PharMingen    (San Diego, CA, USA) 
Promega    (Heidelberg, Germany) 
Promocell    (Heidelberg, Germany)  
Qiagen    (Hilden, Germany)  
R & D Systems GmbH   (Wiesbaden, Germany) 
Riedel-de-Haen   (Seelze, Germany) 
Roche     (Mannheim, Germany)  
Sarstedt    (Nürnbrecht, Gemany) 
Santa Cruz    (Heidelberg, Germany)  
Serotec LTD    (Wiesbaden, Germany)  
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Sigma-Aldrich   (Taufkirchen, Germany)  
Stratagene    (Heidelberg, Germany)  
TPP AG    (Trasadingen, Switzerland) 
USB     (Cleveland, OH, USA) 
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3. Publications 
3.1 Abstracts 
 
H-P Keiss, V.M. Dirsch, T. Hartung, A.M. Vollmar 
 
Extracts from Garlic dry powders modulate LPS-induced liberation of cytokines. 
 
Naunyn-Schmiedeberg's Archieves of Pharmacology, Vol. 365, Suppl. 1  
 
H-P Keiss, S. Schwaiger, M. Dobner, H. Stuppner, A.M. Vollmar, V.M. Dirsch 
 
A lignan from Leontopodium alpinum inhibits the TNF-α-induced expression of  
ICAM-1 and E-Selectin in a NF-κB independent manner. 
 
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 367, Suppl. 1 
 
3.2 Original Publications 
 
V.M. Dirsch, H-P Keiss, A.M. Vollmar  
 
Garlic metabolites fail to inhibit the activation of the transcription factor NF-kappaB 
and subsequent expression of the adhesion molecule E-selectin in human endothelial 
cells 
 
Eur.J.Nutr., in rebuttal 
 
H-P Keiss, V.M. Dirsch, T. Hartung, T. Haffner, L. Trueman, J. Auger, R. Kahane, 
A.M. Vollmar 
 
Garlic (Allium sativum L.) modulates cytokine expression in LPS-activated human 
blood leading to an overall inhibitory effect on NF-κB activity. 
 
J.Nutr., in rebuttal 
 
H-P Keiss, S. Schwaiger, M. Dobner, H. Stuppner, A.M. Vollmar, V.M. Dirsch 
 
A lignan from Leontopodium alpinum inhibits the TNF-α-induced expression of  
ICAM-1 and E-Selectin in a NF-κB-independent manner. 
 
Manuscript in preparation 
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